Global High-Priority Regulatory Events — March 04, 2026

04-03-2026

04-03-2026

04-03-2026

Rise Gold Corp. entered a strategic 18-month development partnership with Morgan Hughes Energy to advance the Idaho-Maryland Mine as a gold and critical-minerals project, issuing 18 million warrants at $0.40 strike price and offering a potential $1.5M milestone payment upon securing capital commitments. Morgan Hughes will support planning, capital formation, and positioning within U.S. critical-minerals initiatives. However, the company faces ongoing regulatory hurdles, including a denied Use Permit by Nevada County Supervisors and a pending Writ of Mandamus with oral arguments on March 6, 2026.

• ·Warrants vest in tranches: 9M on critical-minerals framework advancement, 4.5M on development support, 4.5M on capital commitments.
• ·Morgan Hughes board seat upon qualifying milestone if maintaining 5% ownership.
• ·Alternative to reimbursement: 1.8M warrants for 12 months upon mutual agreement.
• ·I-M Mine historical grades: gold 0.50 oz/ton (17.1 g/t), no domestic U.S. tungsten mine since 2015.
• ·Writ of Mandamus filed May 2024 challenging denial of Use Permit and vested rights.

04-03-2026

Edible Garden AG Incorporated entered into a Note Purchase Agreement dated March 3, 2026, with Streeterville Capital, LLC, issuing a secured promissory note with $1.625M principal for a $1.5M purchase price, incorporating a $120K original issue discount and $5K transaction expenses. The note is secured by all company assets (excluding Tetra Pak-related property) and guaranteed by subsidiaries 2900 Madison Ave Holdings, LLC and Edible Garden Corp., providing immediate cash influx but imposing restrictive covenants limiting future debt, equity issuances, and liens. While offering liquidity, the high OID signals elevated financing costs amid ongoing obligations.

• ·Closing Date: March 3, 2026, via electronic signatures at offices in Lehi, Utah
• ·Collateral excludes all assets, equipment, or property purchased from Tetra Pak, Inc. (including replacements and proceeds)
• ·Covenants restrict Restricted Issuances, new liens (except Tetra Pak assets), subsidiary equity/debt changes, and require timely SEC filings and listing maintenance on NYSE/Nasdaq American

04-03-2026

04-03-2026

Select Medical Holdings Corporation's DEF 14A proxy statement details the 2026 Annual Meeting procedures, with stockholders of record as of February 27, 2026 entitled to vote on 124,018,300 outstanding shares held by 134 registered holders. The Board of 10 directors (8 independent) recommends voting FOR director nominees, executive compensation approval, auditor ratification (PricewaterhouseCoopers LLP), board declassification amendment, and a 25% ownership threshold for special meetings, but AGAINST a stockholder proposal for a 10% threshold. The virtual meeting will be held at 11:00 a.m. EDT, accessible via https://meetnow.global/MKMHXJW.

• ·Board held 8 meetings in fiscal year 2025; each director attended at least 75% of Board and committee meetings.
• ·Annual Meeting stockholder list available for examination starting April 10, 2026 at company offices in Mechanicsburg, Pennsylvania.
• ·Proposal 4 (board declassification) requires majority of outstanding shares; abstentions and broker non-votes count as negative votes.
• ·Proposals 2, 3, 5, 6 require majority of shares present or by proxy; broker non-votes and abstentions have negative effect except for Proposal 1 (director elections by majority of votes cast).

04-03-2026

Transglobal Management Group, Inc. (TMGI), formerly Marquie Group, Inc., filed a Form S-1 registration statement on March 4, 2026, to register securities for a potential public offering under the Securities Act of 1933. The Florida-based radio broadcasting company discloses balance sheet periods ending May 31, 2023, 2024, and 2025, along with extensive related-party transactions including payables to CEO's wife and mother, and numerous notes payable and convertible notes. No specific financial metrics such as revenue or net income are detailed in the filing excerpt, highlighting operational complexity with multiple lenders and service providers.

• ·Fiscal year end: May 31
• ·State of incorporation: Florida
• ·EIN: 262091212
• ·SIC: Radio Broadcasting Stations [4832]
• ·Business address: 7901 4th St. N., Suite 4887, St. Petersburg, FL 33702
• ·SEC file number: 333-293995
• ·Name change from Marquie Group, Inc. to Transglobal Management Group, Inc.: April 15, 2019
• ·Numerous related-party notes payable (e.g., to CEO's wife, mother) and 28+ individual notes payable as of May 31, 2025
• ·13 convertible notes and multiple lenders (A, B, C, D, others) referenced

04-03-2026

Cooper-Standard Holdings Inc.'s subsidiary, Cooper-Standard Automotive Inc., issued $1.1B aggregate principal amount of 9.250% Senior Secured First Lien Notes due 2031 and entered into related security and intercreditor agreements. Proceeds, along with cash on hand, were used to fully redeem $616.9M of higher-rate 13.50% First Lien Notes due 2027 (at 102.250%), $391.8M of 5.625%/10.625% Third Lien Notes due 2027 (at 101.410%), and $42.6M of 5.625% Senior Notes due 2026 (at 100%). The company also amended its ABL Facility to adjust guarantors and covenants, refinancing shorter-term, higher-cost debt with lower-cost, longer-term obligations.

• ·Notes mature on March 1, 2031; interest payable semi-annually on May 15 and November 15, commencing November 15, 2026.
• ·Optional redemption after March 1, 2028 at par plus premiums; prior redemptions include make-whole premium or up to 35% from equity proceeds or 10% at 103%.
• ·Change of Control requires repurchase offer at 101% of principal.
• ·Indenture includes covenants limiting indebtedness, liens, dividends, investments, affiliates transactions, and asset sales.

04-03-2026

Alnylam Pharmaceuticals' Board granted CEO Yvonne Greenstreet a special performance-based equity award of 55,373 target performance share units valued at $18.0M based on the March 2, 2026 closing stock price of $325.07, vesting between 50% and 200% only if average stock price over a 30-day period in late 2029 reaches $500-$800 thresholds (54%-146% increases). Under her leadership, the company achieved nearly 100% stockholder return, met all 'Alnylam P5x25' goals including 2025 profitability, launched AMVUTTRA (including 2025 TTR cardiomyopathy approval), and advanced a pipeline with over 25 programs including three new Phase 3 trials. The award incentivizes achievement of 'Alnylam 2030' goals with full forfeiture if thresholds unmet.

• ·Special Award vesting measured by highest average closing price over 30 consecutive trading days in six months prior to December 31, 2029
• ·Award under Second Amended and Restated 2018 Stock Incentive Plan
• ·Full forfeiture if average stock price does not reach $500 threshold
• ·Form of award agreement to be filed in Q1 2026 10-Q

04-03-2026

CreditRiskMonitor.com, Inc. (CRMZ) announced the termination of Chief Accounting Officer David Reiner's position on February 27, 2026, with his last day being the same date. The company thanked Mr. Reiner for his service. The filing was signed by CEO and President Michael I. Flum on March 4, 2026.

04-03-2026

Promoters of Steel Exchange India Limited disclosed the release of pledged shares by multiple promoters and entities on February 26, 2026, for repayment of debts, reducing prior encumbrances including significant portions from Umashiv Garments Private Ltd (from 19.73% to 11.06% encumbered) and Vizag Profiles Private Limited (from 19.63% to 2.67%). However, the same promoters created new pledges on equivalent shares totaling 24,46,41,910 (19.61% of share capital) as collateral against NCDs and term loans. Total promoter holding remains at 63.36 Cr shares (50.80% of capital), with encumbrance now at 38.61% of promoter shares.

• ·New pledges created as collateral to VISTRA ITCL (INDIA) LIMITED (security trustee).
• ·NCD credit rating: Infomerics Valuation and Rating Limited.
• ·Encumbrance not 20%+ of total share capital or 50%+ of promoter holding.
• ·Disclosure reported to BSE/NSE on March 02, 2026.

04-03-2026

GMR Estate Management Private Limited, holding 46.28% of GMR Power and Urban Infra Limited's shares (361,426,826 shares), has extended an existing pledge on 12 Crore shares (77.19% of its holding and 15.36% of total share capital) in favor of Catalyst Trusteeship Limited to secure additional facilities for GMR Sports Venture Private Limited's unrated, unlisted debentures worth ₹1,350 Cr, with a security cover of ₹1,463.64 Cr (ratio 1.08). This modification, created on February 26, 2026, does not involve a new pledge but increases the debt facility against the same shares previously intimated on January 24, 2025. The encumbrance exceeds 50% of the promoter's shareholding but is below 20% of total share capital.

• ·Encumbrance exceeds 50% of promoter shareholding (YES) but is less than 20% of total share capital.
• ·Entity in whose favor: Catalyst Trusteeship Limited (Debenture Trustee, not a scheduled bank/NBFC).
• ·Relates to debt instruments issued by GMR Sports Venture Private Limited.
• ·Earlier intimation on security/asset cover up to ₹1,000 Cr dated January 24, 2025.
• ·Disclosure signed on March 2, 2026, filed March 4, 2026.

04-03-2026

Dr. Bondada Raghavendra Rao, a promoter of Bondada Engineering Limited, acquired 3,400 equity shares (0.003% of total) on March 2, 2026, via open market purchase, marginally increasing his holding from 50,262,000 shares (45.04%) to 50,265,400 shares (45.043%). The company's total equity share capital remains unchanged at ₹22.32 Cr, divided into 111,593,485 shares of ₹2 each. This minor stake increase reflects promoter confidence but represents negligible change in ownership.

• ·Disclosure filed on March 3, 2026, under Regulation 29(2) of SEBI (SAST) Regulations
• ·No encumbrances, warrants, or other instruments held by the acquirer

04-03-2026

Camlin Fine Sciences Limited has intimated under Regulation 30(6) of SEBI LODR about a group meeting with investors/analysts scheduled for March 10, 2026, at 02:00 PM IST onwards in Mumbai. Discussions will be based solely on publicly available information, with no unpublished price-sensitive information (UPSI) to be shared. The date is subject to change due to exigencies.

• ·Scrip Code: 532834
• ·Symbol: CAMLINFINE
• ·Series: EQ
• ·Addresses: BSE - 25, P. J. Towers, Dalal Street, Mumbai – 400 001; NSE - Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400051

04-03-2026

National Vision Holdings, Inc. reported FY2025 total net revenue of $1.99B, up 9.0% YoY from $1.82B, with comparable store sales growth accelerating to 5.9% from 1.9% driven by America's Best (+6.3%) and other owned segments. The company achieved net income from continuing operations of $29.6M, reversing a $27.2M loss, alongside Adjusted Operating Income of $102.5M (up 56% YoY) and Adjusted EBITDA of $193.0M (up 24%). However, new store openings slowed to 33 from 69, services and plans revenue grew slower at 6.3% versus 9.7% for products, and SG&A expenses rose 8.3% to $1.02B.

• ·Asset impairment declined to $2.0M from $39.9M YoY.
• ·Corporate and other revenue fell to $21.0M (1.0% of total) from $27.6M (1.5%).
• ·Adjusted Diluted EPS from continuing operations rose to $0.80 from $0.52.
• ·Stores in Fred Meyer segment reduced from 29 to 18.

04-03-2026

CDT Environmental Technology Investment Holdings Ltd (CDTG) filed an F-1 registration statement on March 04, 2026, for a proposed IPO of Class A common stock. The filing includes financial statements for the six months ended June 30, 2025 (H1 FY2025) compared to H1 FY2024, and full-year FY2024 vs FY2023, focusing on sewage treatment systems and services through multiple Chinese subsidiaries. No specific financial metrics such as revenue or net income are detailed in the provided excerpt.

• ·Subsidiaries operate primarily in China across locations including Shenzhen, Beijing, Fujian, Tianjin, Chongqing, and others.
• ·Currencies referenced: CNY (Chinese Yuan), HKD (Hong Kong Dollar).
• ·Prior IPO activity noted around April 21-22, 2024.
• ·Balance sheet components include Common Stock, Additional Paid-in Capital, Retained Earnings (Statutory Reserves and Unrestricted), Accumulated Other Comprehensive Income, Noncontrolling Interest.
• ·Property categories: Buildings, Equipment (min/max depreciation), Furniture and Fixtures (min/max), Automobiles (min/max).

04-03-2026

Kontoor Brands reported FY2025 net revenues of $3.15B, up 21% YoY from $2.61B, driven by the Helly Hansen acquisition ($476M), organic growth ($61M), and favorable FX ($8M); gross margin improved to 45.2% from 44.5%. However, operating income declined to $337M (10.7% margin) from $342M (13.1% margin) due to higher SG&A at 34.5% of revenues (vs 31.4%), with Wrangler up 6% in revenue but Lee down 5.1% with profit -23.1%. Helly Hansen contributed $460M revenue with 6.9% margin in its first year.

• ·Repurchased 369,955 shares under public program at weighted avg $67.58/share, $190M remaining authorization.
• ·SG&A expenses rose to 34.5% of revenues from 31.4%.
• ·Wrangler operating margin expanded to 23.0% from 20.3%.
• ·Other revenues surged 153% to $27.8M with margin turning positive at 13.7%.

04-03-2026

Horizon Technology Finance Corporation (HRZN) announced monthly cash distributions of $0.06 per share for April, May, and June 2026, totaling $0.18 per share, payable on April 15, May 15, and June 16, 2026, respectively. Since its 2010 IPO, Horizon has distributed a total of $360M to shareholders. The board's decision factors in results of operations, spillover income, and the anticipated merger with Monroe Capital Corporation (MRCC), with no declines or flat metrics reported.

• ·Ex-Dividend/Record Dates: March 16, 2026 ($0.06); April 16, 2026 ($0.06); May 18, 2026 ($0.06)
• ·Payment Dates: April 15, 2026; May 15, 2026; June 16, 2026
• ·Related SEC Registration Statement: File No. 333-290114
• ·HRZN Proxy Statement filed April 17, 2025 (amended May 15, 2025); MRCC Proxy Statement filed April 21, 2025

04-03-2026

Black Rock Coffee Bar, Inc. (BRCB) grew total stores to 181 from 149 with 32 net new openings, boosting total revenue 24.5% YoY to $200.3M and same-store sales growth to 10.1% from 6.3%, while average unit volume rose to $1.286M from $1.186M. However, income from operations plummeted 85.1% to $0.9M from $6.0M, and net loss widened 130.1% to $16.5M from $7.2M, driven by SG&A expenses surging 63.6% to $41.3M amid rising store operating costs.

• ·Store operating costs and expenses rose 22.2% YoY to $141.6M, with other store operating expenses up 28.4%.
• ·Pre-opening costs increased 28.2% to $4.3M.
• ·Interest expense, net improved 15.9% to $9.4M due to lower expense.
• ·Filing date: March 04, 2026 for year ended December 31, 2025.

04-03-2026

Ziff Davis, Inc. and its subsidiary Ziff Davis, LLC entered into a Securities Purchase Agreement dated March 2, 2026, to sell all outstanding equity interests in specified Transferred Entities (listed on Schedule I) and related Irish assets to Accenture Inc., subject to customary closing conditions and adjustments outlined in Section 2.2. The agreement includes ancillary documents such as an Irish Asset Purchase Agreement, Transition Services Agreement, Escrow Agreement, and employment agreements for Key Employees effective upon closing. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Agreement executed on March 2, 2026; SEC 8-K filed March 4, 2026.
• ·Involves Irish Seller and Specified Irish Assets via separate Irish Asset Purchase Agreement (Exhibit A).
• ·Key Employees (listed in Purchaser Disclosure Schedule Section 1.1(a)) have executed employment agreements conditioned on closing.
• ·Closing subject to conditions in Article IX, including regulatory approvals and no material adverse changes.

04-03-2026

Sky Acquisition Group filed an S-1/A registration statement on March 3, 2026, detailing its proposed IPO of 15,000,000 units, with no units outstanding prior to the offering. Post-offering, the company will have 20,000,000 ordinary shares outstanding (including conversion of 5,000,000 Class B founder shares) and 11,930,000 warrants, following the sponsor's purchase of 5,750,000 Class B founder shares on December 3, 2025, for $25,000. Warrants are exercisable at $11.50 per Class A ordinary share starting 30 days after the initial business combination, with no financial performance metrics or declines reported as this is a pre-operational SPAC.

• ·Separate trading of Class A ordinary shares and warrants prohibited until Form 8-K filed with audited balance sheet post-closing.
• ·Warrants expire 7 years after initial business combination or earlier upon redemption/liquidation.
• ·Up to 750,000 founder shares subject to forfeiture depending on underwriters’ over-allotment option exercise.
• ·Founder shares represent approximately 25% of outstanding shares post-offering on as-converted basis.

04-03-2026

Xponential Fitness reported system-wide sales growth of 13% YoY to $1.75B in 2025, with global studios increasing 7% to 3,097 and franchise revenue rising 10% to $193M, driving operating income of $20M versus a $54M loss in 2024. However, total revenue declined 2% YoY to $315M, same-store sales were flat at 0%, new studio openings dropped 20% to 341, and segments like equipment revenue (-35%) and merchandise (-12%) saw sharp declines, resulting in a net loss of $54M (improved from $99M but worse than 2023's $6M loss). AUV LTM edged up 2% to $695 but quarterly AUV declined 2% to $683.

• ·North America new studio openings net 2025: 160 (global net: 201)
• ·International franchise licenses sold new 2025: 112 (vs North America 67)
• ·Impairment of goodwill and other noncurrent assets 2025: $33M (down from $63M in 2024)
• ·Remaining studios obligated to open under MFAs EOY 2025: 767 (flat from 763 in 2024)

04-03-2026

For FY ended October 31, 2025, MaxsMaking Inc. reported revenue growth of 36.33% YoY to $29.2M, primarily driven by Mainland China sales surging 54.13% to $26.6M. However, cost of sales rose 52.34% leading to a 34.11% decline in gross profit to $2.6M, while operating expenses increased 42.25% and income from operations fell 95.30% to $0.1M, resulting in net income plummeting 99.04% to $18K. Compared to FY2024 (which itself saw revenue decline 18.38% from FY2023), profitability deteriorated sharply despite top-line expansion.

• ·Asia (ex-Mainland China) sales declined 59.44% YoY to $0.8M (2.77% of total), Europe down 29.89% to $1.3M (4.34% of total)
• ·General and administrative expenses surged 132.97% YoY to $1.4M in FY2025
• ·Reliance on PRC subsidiaries for dividends poses cash transfer risks; unpatented technology vulnerable to imitation
• ·IPO consummated July 8, 2025

04-03-2026

Archimedes Tech SPAC Partners II Co. reported total assets of $241.3M as of December 31, 2025, primarily from $239.9M in its Trust Account following its February 12, 2025 IPO of 23M Units, with net income of $8.0M for the year driven by $8.7M in interest income. However, operating losses reached $0.8M from G&A expenses, shareholders' deficit expanded to $6.7M due to $24.6M accretion on redeemable shares, compared to a minor $54k deficit at year-end 2024 pre-IPO. The 2024 inception period showed a $79k net loss with negligible assets.

• ·IPO consummated on February 12, 2025, with full exercise of 3M over-allotment option; 750k sponsor shares no longer subject to forfeiture.
• ·Company inception date: June 7, 2024.
• ·Ordinary shares subject to redemption valued at $10.43 per share as of Dec 31, 2025.
• ·Promissory note to related party of $192k repaid by Dec 31, 2025.

04-03-2026

Alliant Energy Corporation entered into a $400M Credit Agreement dated March 2, 2026, with U.S. Bank National Association as Administrative Agent and CoBank, ACB; Mizuho Bank, Ltd.; and TD Securities (USA) LLC as Joint Lead Arrangers and Joint Book Runners. The facility provides an Aggregate Commitment of $400M, with Applicable Margins of 0.00% for Base Rate Borrowings and 0.85% for Term SOFR Borrowings. No prior period comparisons are available as this is a new financing arrangement.

• ·Filing Date: March 04, 2026
• ·Agreement effective date: March 2, 2026
• ·Alternate Base Rate defined as highest of zero, Prime Rate, Federal Funds Effective Rate + 0.50%, or Term SOFR (1-month) + 1.00%

04-03-2026

FACT II Acquisition Corp. (FACT) filed a Form 425 on March 4, 2026, disclosing a LinkedIn post by Richard Nespola, Jr., sponsor team member, dated March 3, 2026, relating to the proposed business combination with Precision Aerospace & Defense Group, Inc. (PAD). The filing consists primarily of forward-looking statement disclaimers, extensive risk factors including regulatory hurdles, shareholder approvals, and potential redemptions, and directs investors to the pending Form S-4 Registration Statement for details. No financial metrics or performance data are provided.

• ·Commission File Number: 001-42421
• ·Registration Statement on Form S-4 filed with the SEC (not yet effective)

04-03-2026

Cricut, Inc. reported FY2025 total revenue of $709M, down 1% YoY from $713M due to a 5% decline in Products revenue to $381M, despite 5% growth in Platform revenue to $327M. Gross profit rose 11% to $390M with margin expansion to 55% (Platform at 89%, Products up to 26%), driving operating income up 26% to $96M and net income up 22% to $77M. However, sales and marketing expenses increased 11% to $159M while R&D rose 10% to $67M.

• ·Stock-based compensation expense declined to $35M in FY2025 from $45M in FY2024.
• ·Provision for income taxes increased 20% YoY to $31M in FY2025.
• ·Total revenue down 7% from FY2023 $765M peak.
• ·G&A expenses down 6% YoY to $68M but flat at 10% of revenue.

04-03-2026

Charles & Colvard, Ltd. filed a voluntary Chapter 11 bankruptcy petition on March 2, 2026, in the United States Bankruptcy Court for the Eastern District of North Carolina, planning to operate as a debtor in possession while seeking first-day relief for employee wages, vendor payments, insurance, and taxes. The filing may trigger defaults under key agreements, including a Convertible Secured Note with Ethara Capital LLC and a lease with SBP Office Owner, L.P., potentially accelerating obligations though stayed under bankruptcy law. The company cautions that trading in its common stock is highly speculative, with shareholders facing significant or complete loss depending on the Chapter 11 outcome.

• ·Petition Date: March 2, 2026
• ·News release issued: March 3, 2026 (Exhibit 99.1)
• ·Convertible Secured Note Purchase Agreement dated June 24, 2025
• ·Lease Agreement dated December 9, 2013 (amended December 23, 2013, April 15, 2014, January 29, 2021)
• ·Investor relations website: https://ir.charlesandcolvard.com

04-03-2026

NexGen Energy Ltd. filed its Form 40-F annual report for FY ended December 31, 2025, incorporating the Annual Information Form, MD&A, and audited IFRS financial statements for 2025 and 2024, with 659,960,072 common shares outstanding. Short-term compensation to key management personnel decreased 1.4% YoY to $5,950, while share-based payments increased 30.9% YoY to $32,397. Management confirmed effective disclosure controls and no material changes in internal controls over financial reporting.

• ·Audited by KPMG LLP (Auditor Firm ID: 85)
• ·Principal executive offices: Suite 3150, 1021 West Hastings Street, Vancouver, B.C., Canada V6E 0C3
• ·Agent for service in US: Puglisi & Associates, 850 Library Avenue, Suite 204, Newark, Delaware 19711
• ·No off-balance sheet arrangements material to investors
• ·No changes in internal control over financial reporting during FY2025

04-03-2026

Pelican Acquisition Corporation filed a prospectus supplement on March 3, 2026, to the February 18, 2026 prospectus (part of S-4 Registration No. 333-291171), clarifying that PubCo's warrants will not be listed or traded on Nasdaq or any other exchange. This update relates to the ongoing business combination involving Pelican, Greenland Exploration Limited, March GL Company, and Pelican Holdco, Inc., with no other changes to the prospectus. Shareholders are directed to review the full materials for details on the Pelican Shareholder Meeting and related risks.

• ·S-4 Registration No. 333-291171 declared effective February 17, 2026
• ·Prospectus dated February 18, 2026
• ·Pelican 10-Q filing dates: October 31, 2025 (December 19, 2025), July 31, 2025 (September 15, 2025), April 30, 2025 (June 27, 2025)
• ·S-1 effective May 22, 2025

04-03-2026

General Fusion's Chief Strategy Officer Megan Wilson highlighted the company's focus on practical fusion power and the January 21, 2026 Business Combination Agreement with Spring Valley Acquisition Corp. III (SVAC) during a fireside chat at the FusionX:Global Summit on March 3, 2026, noting that the deal provides capital for LM26 milestones. The transaction involves SVAC's continuation to British Columbia, amalgamation with General Fusion via NewCo, and renaming to General Fusion Group Ltd. However, the filing emphasizes significant risks including potential failure to complete the deal, regulatory hurdles, employee retention issues, and commercialization challenges for magnetized target fusion.

• ·Business Combination Agreement dated January 21, 2026
• ·Joint Registration Statement on Form F-4 filed with SEC, including preliminary proxy statement/prospectus
• ·SVAC Final Prospectus dated September 3, 2025, filed September 4, 2025
• ·Filing Date: March 04, 2026; Communication Date: March 3, 2026

04-03-2026

Enhabit, Inc. entered into an Amended and Restated Credit Agreement dated February 26, 2026, which amends and restates the existing Credit Agreement dated June 1, 2022. Wells Fargo Bank, National Association serves as Administrative Agent, Collateral Agent, and Swingline Lender, with multiple banks including BofA Securities, Inc., Capital One, N.A., Regions Bank, JPMorgan Chase Bank, N.A., and Citizens Bank, N.A. acting as Joint Lead Arrangers and Joint Bookrunners. The agreement outlines standard terms for commitments, loans, borrowings, and covenants, with no specific facility sizes or rates detailed in the provided excerpt.

• ·Existing Credit Agreement originally dated June 1, 2022.
• ·SEC 8-K Filing Date: March 04, 2026.
• ·Items reported: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Financial Statements and Exhibits).

04-03-2026

Corvex, Inc. announced on March 3, 2026, the verified production deployment of confidential computing for AI on NVIDIA HGX B200 systems, featuring encrypted GPU-to-GPU communication and remote attestation for secure AI workloads with near-native performance. This achievement supports secure multi-tenant AI environments and is highlighted in the context of Corvex's definitive all-stock merger agreement with Movano Inc. (Nasdaq: MOVE), announced on November 10, 2025. No financial metrics or performance comparisons were disclosed.

• ·Definitive merger agreement (Merger Agreement) announced November 10, 2025
• ·Form S-4 registration statement File No. 333-292321 contains proxy statement/prospectus
• ·Merger is an all-stock transaction
• ·Movano Commission File No.: 001-40254
• ·Movano Annual Report on Form 10-K for year ended December 31, 2024

04-03-2026

This DEF 14A proxy statement solicits shareholder votes for the election of board members at the virtual annual meeting on April 16, 2026, for Nuveen Virginia Quality Municipal Income Fund (NPV) and 15 other Nuveen funds. For NPV, holders of Common and Preferred Shares vote together to elect four Class II Board Members, while Preferred Share holders vote separately to elect two Board Members. The record date is February 9, 2026, with no financial performance metrics disclosed.

• ·Annual Meeting: April 16, 2026, at 2:00 p.m. Central Time, virtual only via meetnow.global/M6VY4FD
• ·Record date: February 9, 2026
• ·Proxy materials mailed on or about March 6, 2026
• ·Quorum: Majority of shares for most votes; 33 1/3% of Preferred Shares for their separate election
• ·Registration for virtual attendance required 3 business days prior if held by intermediary

04-03-2026

This DEF 14A proxy statement for Nuveen Real Estate Income Fund (JRS) and 15 other Nuveen funds solicits shareholder votes for the virtual annual meeting on April 16, 2026, at 2:00 p.m. Central time to elect board members, including four Class II Board Members for JRS voted by common shareholders. No financial performance data or other metrics are disclosed; the filing is purely procedural for governance.

• ·Record date: February 9, 2026
• ·Proxy materials mailed on or about March 6, 2026
• ·Virtual meeting via meetnow.global/M6VY4FD; intermediaries must register 3 business days prior with legal proxy by 5:00 p.m. ET
• ·Quorum: majority of shares for most votes; 33 1/3% of Preferred Shares for certain elections
• ·SEC File Number: 811-10491; CIK: 0001158289

04-03-2026

This DEF 14A filing is a joint proxy statement for the annual shareholder meetings of multiple Nuveen closed-end funds, including Nuveen Real Asset Income & Growth Fund (JRI), scheduled virtually on April 16, 2026, at 2:00 p.m. Central time. Shareholders of record as of February 9, 2026, will vote to elect board members, with JRI seeking election of four Class II Board Members by common shareholders. No financial performance data or period comparisons are provided; the filing outlines voting procedures, quorum requirements, and virtual attendance details.

• ·Record date: February 9, 2026
• ·Proxy materials mailed on or about March 6, 2026
• ·Virtual meeting access: meetnow.global/M6VY4FD
• ·Registration for intermediary-held shares required 3 business days prior, by 5:00 p.m. ET
• ·Quorum: majority of shares entitled to vote; 33 1/3% for Preferred Shares elections in select funds

04-03-2026

Nuveen Variable Rate Preferred & Income Fund (NPFD), along with multiple other Nuveen funds, has issued a joint proxy statement for its virtual Annual Meeting of Shareholders on April 16, 2026, primarily to elect Board Members. For NPFD, this includes electing four Class II Board Members by holders of Common and Preferred Shares voting together as a single class, and two Board Members by Preferred Shares holders voting separately. The record date for shareholders entitled to vote is February 9, 2026, with no financial performance data or changes reported.

• ·Annual Meeting held virtually via live webcast at meetnow.global/M6VY4FD, 2:00 p.m. Central Time on April 16, 2026; no physical location.
• ·Quorum requires majority of shares entitled to vote, or 33 1/3% for Preferred Shares election of two Board Members.
• ·Proxy mailed on or about March 6, 2026; registration for intermediary-held shares required 3 business days prior.
• ·Shares located at 333 W. Wacker Drive, Chicago, IL 60606.

04-03-2026

Gran Tierra Energy Inc. reported a significant net loss of $193.1M for the year ended December 31, 2025, compared to a $3.2M profit in 2024, driven by lower average sales prices ($42.53/boe vs. $60.92/boe, -30% YoY) and a $136.3M asset impairment, despite production NAR volumes surging 38% YoY to 38,443 BOEPD and total annual NAR boe rising 37% to 14.0M. Proved reserves declined 17% to 112 MMBOE, gross profit fell 64% to $66.4M, and Adjusted EBITDA dropped 23% to $283.7M, though net cash from operating activities increased 31% to $313.2M. Segment-wise, Colombia's operating netback plummeted while Ecuador and Canada saw gains.

• ·Senior Notes balance decreased 6% YoY to $740.5M with no credit facility draw as at Dec 31, 2025.
• ·Colombia operating netback declined to $240.0M in 2025 from $379.9M in 2024.
• ·Ecuador gross profit improved to $5.5M in 2025 from $2.3M in 2024.
• ·Q4 2025 net loss was $141.1M, including $136.3M asset impairment.

04-03-2026

Babcock & Wilcox reported Q4 2025 revenue of $161.0 million, essentially flat YoY compared to $161.8 million, but delivered strong profitability with operating income of $12.2 million (up from $2.6 million) and Adjusted EBITDA of $16.4 million (53% increase from $10.7 million). Full year 2025 revenue increased slightly by 1.2% to $587.7 million alongside a 107% surge in Adjusted EBITDA to $43.7 million, though the company still recorded a $32.8 million loss from continuing operations (improved from $104.3 million prior year). Key highlights include signing full notice to proceed on a $2.4 billion AI data center project with Base Electron, boosting continuing operations backlog to $2.8 billion (470% YoY increase) and reducing net debt to $119.7 million.

• ·Paid off outstanding bonds due February 2026 in December 2025; plans to pay off December 2026 bonds in 2026.
• ·Earnings conference call scheduled for March 16, 2026 at 5 p.m. ET.
• ·Extended maturity date of Axos facility.

04-03-2026

FactSet announced the appointments of Kate Stepp as Chief AI Officer and Bob Stolte as Chief Technology Officer, effective March 2, 2026, to accelerate enterprise AI and platform strategy, with both reporting to CEO Sanoke Viswanathan. Kate Stepp previously served as CTO since September 2022, focusing on client-centric technology and AI expansion. These leadership changes reinforce FactSet's commitment to AI innovation, serving more than 9,000 global clients and 239,000 users across 19 countries.

• ·Kate Stepp held the role of Chief Technology Officer since September 2022.
• ·Appointments announced on March 4, 2026.

04-03-2026

Gandhar Oil Refinery (India) Limited received a GST summons under Section 70 of the CGST Act, 2017, from Superintendent Vikendra Kumar Meena at GST Bhavan, Vapi, requiring appearance on March 10, 2026, at 10:30 AM to provide documents on transactions with M/s Maruti Petroleum. The inquiry is preliminary with no violations alleged and no quantifiable financial or operational impact determined yet. The company disclosed this under Regulation 30 of SEBI LODR on March 4, 2026, after receiving the summons via email on March 3, 2026.

• ·GSTIN of Maruti Petroleum: 24MQOPS5743L1ZT
• ·Summons reference: GEXCOMAE/F/70/202-E-O/COMMRCGSTDAMAN 14065712026
• ·CBIC DIN: 20260365TB0000111
• ·Company GSTIN: 26AAACG3996J1Z8

04-03-2026

Altisource Portfolio Solutions S.A. reported total revenue of $171M for the year ended December 31, 2025, up 7% YoY from $160M, driven by 16% growth in Origination service revenue to $35M and 5% increase in Servicer and Real Estate to $126M. However, gross profit declined 1% to $49M with margins contracting to 30% from 33%, income from operations fell 87% to $0.4M impacted by a $7.5M litigation settlement loss, and Marketplace revenue dropped 10% to $24M while Technology and SaaS Products declined 11% to $9M. The company achieved a net income attributable to Altisource of $1.6M, swinging from a $36M loss in 2024, supported by a 69% reduction in interest expense.

• ·REO Inventory - Customers other than Rithm increased 230% to 2.4 (in thousands) as of Feb 15, 2026 from 0.7.
• ·REO Inventory - Rithm remained flat at 1.0 (in thousands) as of Feb 15, 2026.
• ·Corporate and Others segment reported operating loss of $32.8M in 2025 vs $34.8M in 2024.
• ·SG&A expenses decreased 10% to $41M in 2025.
• ·Filing date: March 04, 2026 for year ended December 31, 2025.

04-03-2026

The Real Brokerage Inc. (REAX) filed its Form 40-F Annual Report for the fiscal year ended December 31, 2025, incorporating by reference its Annual Information Form, audited consolidated financial statements, and Management’s Discussion and Analysis. The company reported 210.5 million outstanding common shares as of December 31, 2025, with no long-term debt, capital leases, operating leases, purchase obligations, or other long-term liabilities (all $0). No material changes in internal control over financial reporting were noted, and the Audit Committee is led by financial expert Larry Klane.

• ·No changes in internal control over financial reporting during FY 2025.
• ·No off-balance sheet arrangements.
• ·Shareholder quorum requirement: at least 5% of issued common shares.
• ·Exempt from certain Nasdaq rules as foreign private issuer (e.g., proxy solicitation follows Canadian rules).
• ·Code of Business Conduct and Ethics applies to all directors, officers, and employees.

04-03-2026

SSR Mining Inc. entered a binding memorandum of understanding to sell its 80% ownership in the Çöpler mine and related properties to Cengiz Holding A.S. for $1.5B in cash, payable at closing, with a $100M deposit and $50M reciprocal break fee. The transaction excludes the Hod Maden development project, is expected to close in Q3 2026 subject to Turkish regulatory approvals and limited due diligence, and is deemed fair by CIBC's fairness opinion. Proceeds will fund reinvestment, capital returns, and growth, repositioning the portfolio toward Americas operations including the Cripple Creek & Victor mine.

• ·Fairness opinion issued by CIBC World Markets Inc. on March 3, 2026
• ·Transaction not subject to financing contingency or operational permits
• ·Legal advisors: Allen Overy Shearman Sterling LLP
• ·Expected closure: third quarter of 2026
• ·SSR Mining retains 20% interest in Hod Maden project

04-03-2026

H.B. Fuller Company's DEF 14A proxy statement, filed March 4, 2026, details the virtual 2026 Annual Meeting on April 16, 2026, at 10:00 a.m. CT, with proposals to elect three directors for a three-year term until the 2029 Annual Meeting, ratify Ernst & Young LLP as independent auditors for the fiscal year ending November 28, 2026, and conduct a non-binding advisory vote on named executive officer compensation. The record date is February 18, 2026, and the filing includes XBRL-tagged disclosures on PEO and Non-PEO NEO compensation adjustments across fiscal years ending November 2021 through November 2025, covering equity awards, pensions, and fair value changes. No specific quantitative compensation figures or period-over-period changes are detailed in the provided content.

• ·Meeting accessible virtually at www.virtualshareholdermeeting.com/FUL2026; 16-digit control number required.
• ·Payment of filing fee: No fee required.
• ·Fiscal periods referenced: 2020-11-29 to 2021-11-27, 2021-11-28 to 2022-12-03, 2022-12-04 to 2023-12-02, 2023-12-03 to 2024-11-30, 2024-12-01 to 2025-11-29.

04-03-2026

On March 3, 2026, the NYSE suspended trading in Vicarious Surgical Inc.'s Class A common stock (RBOT) after determining the company's average global market capitalization fell below the $15M threshold over a consecutive 30 trading day period under Section 802.01B, and commenced delisting proceedings via Form 25 following any appeal. The company is evaluating an appeal within 10 business days and has approval to quote on the OTCID market tier starting March 4, 2026, but this shift to a less liquid OTC market is expected to depress the stock price, reduce liquidity, limit equity financing access, and impair employee equity incentives. No positive financial metrics or performance improvements were reported.

• ·Appeal of delisting determination must be filed within 10 business days of March 3, 2026 notification.
• ·Company headquartered at 78 Fourth Avenue, Waltham, MA 02451.

04-03-2026

On February 27, 2026, Timothy Go resigned from the Board of Directors of Celanese Corporation, effective as of that date. The resignation is not the result of any disagreement with the Company's operations, policies, or practices. The Board and Company expressed gratitude for Mr. Go’s service as a Director.

• ·Filing date: March 4, 2026
• ·Event reported date: February 27, 2026
• ·Registrant state of incorporation: Delaware
• ·Commission File Number: 001-32410
• ·IRS Employer Identification No.: 98-0420726

04-03-2026

Advanced Flower Capital Inc. (AFCG) reported a net loss of $20.7M for the year ended December 31, 2025, compared to net income of $16.8M in 2024, primarily due to a 40% YoY decline in interest income to $31.3M, sharply higher provisions for credit losses at $22.6M (vs $4.2M), and unrealized losses on loans. Distributable earnings dropped 75% YoY to $8.7M amid a contracting loan portfolio with total outstanding principal at $317.4M (down from $301.8M). While expenses decreased slightly to $15.7M and there was a $0.4M gain on debt extinguishment, net interest income fell 46% YoY to $24.6M.

• ·Fair value of loans decreased to $26.1M as of 12/31/2025 from $30.5M as of 12/31/2024.
• ·Loan repayments of $60.6M and amortization payments of $18.2M contributed to portfolio contraction in 2025.
• ·New fundings totaled $41.7M in 2025.
• ·Weighted average remaining life of loans at carrying value shortened to 1.4 years as of 12/31/2025 from 1.9 years as of 12/31/2024.
• ·Largest loan exposure: Sub of Private Co. G at 22.0% of total AFC ($78.8M principal).

04-03-2026

Cellectar Biosciences' total assets declined 41% YoY to $15.0M as of December 31, 2025 from $25.5M in 2024, driven by a 43% drop in cash and cash equivalents to $13.2M. While total liabilities improved 48% to $5.1M, highlighted by an 87% reduction in warrant liability to $0.23M, stockholders' equity fell 40% to $8.5M due to a $21.8M increase in accumulated deficit. Common shares outstanding more than doubled to 4.24M, with additional paid-in capital up 6% to $277M.

• ·Filing date: March 04, 2026
• ·Property, plant & equipment, net: $0.55M (2025) vs $0.76M (2024)
• ·Operating lease right-of-use asset: $0.36M (2025) vs $0.44M (2024)
• ·Accounts payable and accrued liabilities: $4.4M (2025) down 42% from $7.6M (2024)

04-03-2026

TScan Therapeutics reported collaboration and license revenue of $10.3M for the year ended December 31, 2025, a 267% YoY increase from $2.8M. However, operating expenses rose 6% to $146.1M, resulting in a net loss of $129.8M, up 2% from $127.5M in 2024, while cash used in operating activities increased 22% to $135.3M and cash equivalents fell to $152.4M from $178.7M.

• ·Clinical studies expenses declined $2.4M to $16.8M in 2025 from $19.2M in 2024.
• ·Interest and other income, net decreased $3.2M to $8.8M in 2025.
• ·Marketable securities balance dropped to $0 from $111.4M at Dec 31, 2024.
• ·Stock-based compensation increased to $11.7M in 2025 from $9.5M in 2024.
• ·Accumulated deficit grew to $504.9M from $375.1M.

04-03-2026

Cyient Limited disclosed that the National Company Law Tribunal (NCLT) Bengaluru Bench has ordered the commencement of the liquidation process for Infotech HAL Limited, its 50:50 joint venture with HAL, under Sections 33(2) & 34(1) of the Insolvency and Bankruptcy Code, 2016. Mr. Vasudevan Gopu has been appointed as the Liquidator, with the order received on 3 March 2026. This development follows prior disclosures on 20 March 2024 and 28 August 2025.

• ·NCLT admitted Interlocutory Application No. (Liq.) 01/2026 in petition CP (IB) No. 99/BB/2024.
• ·Scrip Codes: BSE - 532175, NSE - CYIENT.
• ·Cyient CIN: L72200TG1991PLC013134.

04-03-2026

TV Vision Limited received a copy of an insolvency petition filed by Punjab National Bank (PNB), a financial creditor, under Section 7 of the Insolvency and Bankruptcy Code, 2016, at the National Company Law Tribunal (NCLT), Mumbai. The petition alleges an outstanding amount of ₹294.43 Cr, which the company considers material and potentially impactful on its operations and financial position. The company has committed to providing updates on further developments.

• ·Scrip No.: 540083, Symbol: TVVISION
• ·CIN: L64200MH2007PLC172707

04-03-2026

A. O. Smith Corporation's DEF 14A Proxy Statement, filed March 4, 2026, solicits votes for the 2026 Annual Meeting on April 13, 2026, at The Ritz-Carlton in Charlotte, NC, including electing the Board of Directors (six by Class A Common stockholders, four by Common stockholders), an advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as independent auditors for FY 2026. Record date is February 17, 2026, with 25.9M Class A Common shares and 112.4M Common shares outstanding entitled to vote. The statement highlights the transition to new CEO Steve Shafer under Executive Chairman Kevin J. Wheeler, with no financial performance metrics or period-over-period comparisons provided.

• ·Class A Common Stock: 1 vote per share for all matters; Common Stock: 1 vote for directors, 1/10th vote for other matters.
• ·Quorum requires majority of outstanding shares; directors elected by plurality vote per class.
• ·Pre-registration for meeting required by April 10, 2026; stockholder list available April 3, 2026.

04-03-2026

BF Investment Limited disclosed fines of ₹2.71L each (inclusive of GST) from NSE and BSE for non-compliance with Regulation 17(1) of SEBI Listing Regulations due to failure to appoint an independent woman director after a resignation. The company promptly paid the fines on March 02, 2026, ahead of the March 14, 2026 due date, and stated no material impact on financials or operations. It is actively identifying a suitable candidate to rectify the board composition.

• ·Date of receipt of direction from NSE/BSE: February 27, 2026
• ·Due date of payment: March 14, 2026
• ·Disclosure filed under Regulation 30 of SEBI LODR
• ·Payment made on March 02, 2026 after reviewing communication post non-working days

04-03-2026

BF Utilities Limited disclosed receiving fines of ₹2.71L each (total ₹5.42L inclusive of GST) from NSE and BSE on February 27, 2026, for non-compliance with Regulation 17(1) of SEBI Listing Regulations due to failure to appoint an Independent Woman Director after a resignation. The company promptly paid the fines on March 02, 2026, ahead of the March 14, 2026 due date, and stated there is no material impact on financials or operations. It is actively identifying a suitable candidate to comply with board composition requirements.

• ·Correspondence from NSE and BSE received after working hours on February 27, 2026; payment processed on March 02, 2026 after review on first working day.
• ·Violation details: Non-compliance with Regulation 17(1) pertaining to board composition, specifically Regulation 17(1)(c).

04-03-2026

On March 3, 2026, Hexcel Corporation entered into a Cooperation Agreement with Vision One Fund, LP and affiliates, appointing Neal J. Keating to the Board of Directors and Audit Committee, nominating him for the 2026 Annual Meeting, and limiting Board size to 10 directors until the 2026 Annual Meeting and 9 thereafter until the Expiration Date. Vision One Parties agreed to withdraw their 2026 Annual Meeting nominees, adhere to standstill restrictions, and vote for Board nominees. No financial terms or impacts were disclosed.

• ·Board size limited to no more than 10 directors until 2026 Annual Meeting and 9 directors from 2026 Annual Meeting until Expiration Date (earlier of 30 days prior to 2027 stockholder nomination deadline or 150 days prior to 2026 Annual Meeting one-year anniversary).
• ·Neal J. Keating, age 70, previously Chairman, President, and CEO of Kaman Corporation (2008-2020), Executive Chairman until 2021; COO of Hughes Supply; CEO of GKN Aerospace.
• ·Mr. Keating serves on Hubbell Incorporated board since 2010 (chairs nominating/governance committee); former lead director of Triumph Group (2022-July 2025) and Barnes Group Inc. (2023-2025).
• ·No arrangements or understandings other than Cooperation Agreement for appointment; no reportable related party transactions under Item 404(a).

04-03-2026

04-03-2026

Tivic Health Systems, Inc. (Nasdaq: TIVC) appointed Michael K. Handley as CEO effective March 4, 2026, succeeding Jennifer Ernst, who has led since the company's founding in 2016 and will continue supporting the transition. The leadership change supports a strategic pivot to late-stage immunotherapies and biopharma expansion via the Velocity Bioworks CDMO subsidiary. Handley brings over two decades of experience, including US approvals and commercialization of 17 products generating billions in revenue at Amgen and Genentech.

• ·Tivic founded in 2016; Annual Report on Form 10-K for year ended December 31, 2024, filed March 21, 2025.
• ·Velocity Bioworks is a wholly owned full-service CDMO subsidiary based in San Antonio, Texas.
• ·Entolimod™ is a TLR5 agonist in late-stage development for Acute Radiation Syndrome (ARS) under FDA’s Animal Rule.

04-03-2026

Tevogen Bio Holdings Inc. adopted a Certificate of Amendment to its Certificate of Incorporation, authorizing a 1-for-50 reverse stock split of its common stock, effective March 6, 2026, at 12:01 a.m. ET, with no fractional shares issued and cash payments in lieu thereof. Authorized capital stock remains 820M total shares, comprising 800M common shares and 20M preferred shares, each with $0.0001 par value. The amendment was approved by the Board and stockholders without changes to other sections.

• ·Reverse split applies automatically without further action by holders.
• ·Filed with Delaware Secretary of State; executed March 3, 2026.

04-03-2026

Haymaker Acquisition Corp. 4 entered into Investor Support Agreements on March 3, 2026, with holders of approximately 49.8% of its outstanding public warrants, agreeing to exchange them for $2.25 in cash and 0.075 Ordinary Shares per warrant, totaling about $25.9M and 862,500 shares, immediately prior to the Business Combination closing. The Sponsor also committed support for its private placement warrants, securing majority approval for the Warrant Amendment at the upcoming Warrantholder Meeting. No financial performance metrics are reported, but the agreements advance the previously announced merger with Suncrete, Inc. and Concrete Partners Holding, LLC.

• ·Business Combination Agreement originally entered October 9, 2025
• ·Warrant exchange to occur immediately prior to Business Combination closing
• ·Approval requires majority of outstanding SPAC Warrants; Haymaker retains sole discretion to proceed post-approval
• ·Exchange relies on Section 3(a)(9) exemption from Securities Act registration

04-03-2026

Nexxen International Ltd. (NEXN) filed its 20-F Annual Report on March 04, 2026, defining key non-GAAP metrics including Contribution ex-TAC (gross profit plus depreciation/amortization attributable to cost of revenues minus TAC), Adjusted EBITDA (adjusted for foreign currency, financing, tax, depreciation, stock-based compensation, restructuring, acquisition-related costs, delisting costs, and other expenses), active customers/publishers (users of platform in trailing 365 days), unique users (unduplicated visitors in one-month period), and Contribution ex-TAC retention rate (from prior-year customers). The filing highlights forward-looking risks such as dependence on adding new advertisers/publishers and platform usage growth, as well as reliance on a limited number of DSPs, agencies, and advertisers for ad spend, which could be reduced or terminated.

04-03-2026

Azenta, Inc. (AZTA) completed the strategic acquisition of UK Biocentre Limited through its subsidiary Azenta UK Ltd for total consideration of GBP 20.5 million net of cash, inclusive of up to GBP 1.8 million in contingent consideration. UK Biocentre, which generated GBP 15.3 million in revenue over the twelve months ending September 30, 2025, will operate as a European hub to expand Azenta's biorepository capabilities. On a pro forma basis, the acquisition is expected to dilute 2026 Adjusted EBITDA margin by 35 basis points, while being accretive to 2027 and 2028 organic revenue growth and Adjusted EBITDA margin expansion.

• ·Conference call and webcast scheduled for March 10, 2026 at 10:00 am Eastern Time; replay available March 11, 2026.
• ·UK Biocentre founded in 2014.
• ·Azenta headquartered in Burlington, MA, with operations in North America, Europe, and Asia.

04-03-2026

KALA BIO, Inc. announced a strategic initiative to deploy an on-premises AI infrastructure platform 'Researgency' for the biotech industry, entering into a Platform Development and Exclusive License Agreement with Younet AI (2624465 Ontario Inc.) for an exclusive worldwide license in biotechnology for an initial 12-month term with renewal options. The company will first apply it internally to its MSC-S biological datasets and KPI-012 clinical program before scaling to external clients via a platform-as-a-service model to generate recurring revenue. This targets an underserved market where the top 20 pharmaceutical companies invested $167B in R&D in 2024, with AI drug discovery spending projected to grow from $4B in 2025 to $25B by 2030.

• ·Exclusive worldwide license for Researgency in biotechnology field
• ·Initial 12-month term with successive 12-month renewal options at KALA's discretion
• ·Phased rollout: Phase 1 internal validation on KALA data; Phase 2 external licensing; Phase 3 platform expansion
• ·Over 3,200 US biotech companies as potential addressable market for on-premises AI
• ·Younet AI experience deploying 100+ custom AI agents across sectors

04-03-2026

Alerus Financial Corp reported net interest income surging 61.1% YoY to $172.5M in 2025, fueled by a wider net interest margin of 3.53%, while retirement and benefit services AUA grew 10.3% to $44.9B and mortgage originations doubled to $484.8M. However, noninterest income plunged 54.9% YoY to $51.9M, noninterest expenses rose 11.4% to $201.2M, resulting in net income dipping 1.9% to $17.4M, diluted EPS falling to $0.68 from $0.83, and ROA declining to 0.33%. Loans increased modestly 1.4% to $4.05B, but deposits contracted 4.2% to $4.19B and nonperforming loans rose to 1.71%.

• ·Provision for loan losses decreased sharply to $556K from $18.1M YoY.
• ·Investment securities declined to $768.5M from $863.6M.
• ·Efficiency ratio worsened to 84.10% from 77.92%.
• ·Dividend payout ratio increased to 122.06% from 95.18%.
• ·Allowance for credit losses coverage of nonperforming loans fell to 89.65% from 95.30%.

04-03-2026

Boxabl Inc. issued a promotional newsletter via StockTwits highlighting its SPAC merger with FG Merger II Corp. (FGMC), including a deadline extension to March 31, 2026, pending regulatory and shareholder approvals, following the merger agreement signed on August 4, 2025. Boxabl touted its $230M crowdfunding from over 60,000 investors since 2020 and products like the 361 sq ft Casita and 120 sq ft Baby Box. However, the communication emphasizes significant risks, including potential shareholder redemptions, regulatory delays, historical net losses, and failure to achieve commercialization.

• ·Boxabl founded in 2017
• ·FGMC final prospectus filed with SEC on January 29, 2025
• ·Boxabl Annual Report on Form 10-K filed April 14, 2025
• ·FGMC CIK: 1816937
• ·Surviving entity to be renamed BOXABL Inc. with ticker $BXBL
• ·FGMC address: 104 S. Walnut Street, Unit 1A, Itasca, Illinois 60143
• ·Boxabl address: 5345 E North Belt Rd, Las Vegas NV 89115

04-03-2026

Ventyx Biosciences, Inc. (VTYX) filed an 8-K on March 04, 2026, including its Fourth Amended and Restated Certificate of Incorporation (Exhibit 3.1), coinciding with Items 2.01 (acquisition completion), 3.01, 3.03, 5.01 (change in control), 5.02 (director departures), 5.03 (new directors), and 9.01. The certificate updates the business address to Eli Lilly and Company Global Headquarters in Indianapolis, Indiana, and reduces authorized common stock to 100 shares at $0.0001 par value per share. No financial metrics or performance data are provided in the exhibit.

• ·Registered office: 1209 Orange Street, Wilmington, New Castle County, Delaware 19801.
• ·Directors may be removed with or without cause by majority vote of common stockholders.
• ·Standard indemnification and liability protections for directors and officers affirmed.

04-03-2026

Invech Holdings, Inc. (IVHI) entered into an Asset Purchase Agreement and completed the acquisition of the domain www.paragonrentals.ai, along with logo, code base, front end, backend, and admin panel, from Andrew Chase Cochran for a total purchase price of $450,000, financed via a Convertible Promissory Note. The note carries no interest, is payable in full by March 3, 2027, or automatically convertible into 10,000,000 shares of IVHI common stock at $0.045 per share, with conversion mechanics limiting the holder to no more than 9.9% ownership. The transaction closed on March 3, 2026, with assets sold 'as is' and no warranties beyond those stated.

• ·Convertible Promissory Note payment due date: March 3, 2027 (or earlier prepayment or automatic conversion)
• ·Note is non-interest bearing and sold 'as is' with no express or implied warranties except as stated
• ·Governing law: Alabama
• ·Holder ownership cap upon conversion: 9.9% of common stock
• ·Company address: 1603 Capitol Ave Suite 413 PMB 1777, Cheyenne, WY 82001

04-03-2026

SunOpta Inc. reported FY2025 revenues of $818M, up 13.0% YoY from $724M, driven by 13.5% volume/mix growth in beverages, broths, and fruit snacks, though partially offset by a -0.2% price impact and -0.3% from smoothie bowls exit. Gross profit rose 20.4% to $116M with margin expansion to 14.2% (up 0.9pt), and operating income surged 154.6% to $40M (margin 4.9%, up 2.7pt), leading to net earnings of $16M from a prior loss of $17M; however, COGS increased 11.8%, other non-operating expense rose 213%, and non-cash asset impairments totaled $3.2M.

• ·FY2025 revenue drivers: volume/mix +$97M (13.5%), price -$1M (-0.2%), smoothie bowls exit -$2M (-0.3%)
• ·FY2024 vs FY2023: revenues up 15.5% to $724M, but gross margin declined 0.4pt to 13.3%; SG&A flat at +1.0%
• ·Gross profit FY2025 improvements included $16M lower start-up costs and $14M higher volumes, offset by $10M labor/infrastructure investments and $2M depreciation
• ·Operating income FY2025 aided by $6M lower op ex (incl. consultancy savings) and $4M lower stock comp, but hurt by $3M impairments and $2M prior gain reversal
• ·Midlothian, Texas facility: $1M savings from lower wastewater charges

04-03-2026

Winmark Corporation's DEF 14A proxy statement solicits votes for its Annual Meeting on April 22, 2026, proposing to set the Board at seven members and elect seven directors, including incumbents Brett D. Heffes and Lawrence A. Barbetta; an advisory vote on executive compensation; and ratification of Grant Thornton LLP as auditors for fiscal 2026. The record date is March 2, 2026, with 3,577,421 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period changes are detailed in the filing.

• ·Annual Meeting location: 605 Highway 169 N, Suite 100, Minneapolis, Minnesota 55441 at 3:00 p.m. Central Daylight Time
• ·Record date voting eligibility: close of business on March 2, 2026
• ·Proxy materials first mailed on or about March 18, 2026
• ·Proxy solicitation by Brett D. Heffes and Anthony D. Ishaug if no board recommendation

04-03-2026

Crown Holdings, Inc. (NYSE: CCK) elected packaging industry executive Michael P. Doss to its Board of Directors, effective March 3, 2026, expanding the board to ten members. Doss, former President, CEO, and Director of Graphic Packaging Corporation (2016-2025), also serves as a director at Regal Rexnord Corporation since 2023. Chairman and CEO Timothy J. Donahue praised Doss's expertise in packaging, manufacturing, and governance.

• ·Announcement dated February 26, 2026.
• ·SEC 8-K filing date: March 04, 2026.
• ·Doss's prior roles at Graphic Packaging span 25+ years.

04-03-2026

Joint definitive proxy statement for the annual stockholder meeting of nine Cohen & Steers closed-end funds, including Cohen & Steers Real Estate Opportunities & Income Fund (RLTY), to elect three Directors for each Fund for terms ending at the 2029 annual meeting. The meeting is scheduled for April 22, 2026, at 10:00 a.m. ET in New York, NY, with a record date of February 13, 2026. No financial performance data or period-over-period comparisons are provided in the filing.

• ·Proxy materials first mailed on or about March 11, 2026
• ·Quorum requires holders of a majority of shares outstanding for each Fund
• ·Meeting may be adjourned up to 120 days after record date if quorum not present
• ·RLTY fiscal year end: March 15; PTA fiscal year end: October 31; others December 31

04-03-2026

BSE Limited and National Stock Exchange of India Limited imposed fines of ₹2.17 lakh each (inclusive of GST) on Lotus Eye Hospital and Institute Limited for non-compliance with Regulation 17(1A) of SEBI (LODR) Regulations, 2015, pertaining to the quarter ended December 31, 2025; the directions were received on February 27, 2026. The company has rectified the non-compliance via shareholder approval through postal ballot deemed passed on January 17, 2026, and reports no material impact on financials or operations. Previous fines for quarters up to September 2025 have been paid.

• ·CIN: L85110TZ1997PLC007783
• ·Scrip Codes: BSE 532998, NSE LOTUSEYE
• ·Board discussed non-compliance at meeting on February 11, 2026, and disseminated to exchanges on February 11, 2026

04-03-2026

Regional Health Properties, Inc. and Erin Property Holdings, LLC entered into Forbearance Agreements with Cadence Bank, N.A. on February 27, 2026 (effective February 1, 2026) due to defaults on the USDA Note ($5M principal) and SBA Note ($800K principal), both due July 27, 2036. The agreements require immediate payments of $21,047.76 (one-time forbearance) and $6,764.21 (USDA renewal fee), with monthly principal and interest payments during the Forbearance Period ending February 1, 2027, after which full balances including late fees are due. This provides temporary relief from remedies but highlights ongoing payment defaults and obligations.

• ·Forbearance Agreements attached as Exhibits 10.1 (USDA Note) and 10.2 (SBA Note).
• ·Notes issued pursuant to Security Agreement dated July 27, 2011.
• ·During Forbearance Period, interest continues to accrue per original Note terms.

04-03-2026

Ocugen, Inc. reported total revenue of $4.4M for the year ended December 31, 2025, up 9% YoY from $4.1M, entirely from collaborative arrangements. However, R&D expenses surged 24% to $39.8M and total operating expenses rose 14% to $67.3M, driving operating losses to widen 15% YoY to $62.9M and net loss to expand 25% to $67.8M. Cash and restricted cash plummeted 68% to $18.9M, with net cash used in operations increasing 35% to $57.0M and stockholders' equity turning negative at $12.2M from $29.6M.

• ·Net cash provided by financing activities declined 73% YoY to $17.3M from $64.9M.
• ·Interest expense rose sharply to $5.2M from $0.7M due to higher debt.
• ·Diluted EPS worsened to $(0.23) from $(0.20).
• ·Common shares outstanding increased to 312.4M from 291.4M.
• ·Series B Convertible Preferred Stock fully reacquired in 2024.

04-03-2026

AmBase Corporation entered into a Litigation Funding Agreement (RAB 2026 LFA) with CEO Richard A. Bianco for up to $6M to fund operations and the 111 West 57th Property litigation, including conversion of $4M existing promissory notes and $2M in new cash infusions. BARC Investments LLC simultaneously converted its $2M note (plus ~$200k accrued interest) into a pari-passu LFA (BARC 2026 LFA). However, these deals dilute future litigation proceeds significantly, with funders prioritized for up to 1.8x multiples on funding amid persistent going concern qualifications and uncertain litigation outcomes requiring additional capital.

• ·Accrued interest on RAB and BARC notes matures in 3 years from end of execution month.
• ·Funding approved by Special Committee of one independent director, advised by outside counsel.
• ·Litigation funding terms evaluated as fair despite prior unsuccessful third-party funding search.
• ·Company continues to seek additional capital; no assurance of success or litigation recovery.

04-03-2026

Moody’s Corporation's 2026 Proxy Statement outlines the virtual Annual Meeting of Stockholders on April 14, 2026, at 9:30 a.m. EDT, with stockholders voting on electing ten director nominees for one-year terms, ratifying KPMG LLP as independent auditors for 2026, and an advisory resolution on executive compensation. The record date is February 18, 2026, and proxy materials were made available starting March 4, 2026. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/MCO2026
• ·Company address: 7 World Trade Center, 250 Greenwich Street, New York, New York 10007
• ·Investor Relations contact: ir@moodys.com or (212) 553-0300
• ·2025 Annual Report covers year ended December 31, 2025

04-03-2026

Texas Instruments Incorporated (TXN) filed its DEF 14A Proxy Statement on March 4, 2026, for the 2026 annual stockholder meeting on April 16, 2026, at 12500 TI Boulevard, Dallas, TX, with a record date of February 23, 2026. Key matters include election of 12 directors (11 independent), advisory approval of executive compensation, ratification of Ernst & Young LLP as independent auditors for 2026, and a stockholder proposal to permit action by written consent. The board emphasizes diverse qualifications including executive leadership, financial acumen, and industry knowledge, with a mandatory retirement age of 75 to balance tenure.

• ·Quorum requires majority of outstanding shares present in person or by proxy; majority vote of votes cast required for director elections, advisory votes, ratification, and stockholder proposal.
• ·Advance registration required for in-person attendance by April 15, 2026, with government-issued photo ID; weapons, cameras, and recording devices prohibited.
• ·Board has 12 nominees, all current directors; substitutes possible if unavailable.

04-03-2026

Sensus Healthcare reported revenues of $27.5M for FY 2025, a 34% YoY decline from $41.8M, resulting in a net loss of $7.7M compared to net income of $6.6M in FY 2024, driven by higher R&D ($7.8M, +85%) and selling expenses ($6.5M, +31%). While cash and equivalents remained stable at $22.1M and operating cash flow improved to positive $0.5M from negative $0.8M, total assets fell 15% to $53.0M amid a sharp 69% drop in accounts receivable to $6.0M.

• ·Stock repurchases of 50,360 shares for $0.3M in FY 2025.
• ·Deferred tax assets increased to $4.1M from $2.2M.
• ·Total stockholders’ equity declined to $48.1M from $55.8M.
• ·Company notes potential need for additional funding in future.

04-03-2026

Westlake Chemical Partners LP's 2025 annual results showed total net sales of $1.17B, up 2.7% YoY from $1.14B, with net sales to Westlake rising 8.7% to $1.03B while third-party co-products sales declined 28% to $133M; the increase was driven by 10.4% higher average sales prices offsetting an 8.2% volume drop. However, gross profit fell 17% to $348M amid 50.7% higher natural gas fuel costs and 32.8% higher ethane feedstock costs, resulting in income from operations down 18% to $320M, net income to LP down 22% to $48.7M (or $1.38 per unit from $1.77), and MLP distributable cash flow down 20% to $53.4M. EBITDA decreased 11% to $450M, and net cash from operations dropped sharply 42% to $280M.

• ·Property, plant and equipment, net declined to $886M from $904M.
• ·Long-term debt payable to Westlake stable at $400M.
• ·Distributions to unitholders remained flat at approximately $66M.
• ·Cash and cash equivalents ended at $44M, down from $58M.

04-03-2026

At the Jack in the Box Inc. annual shareholder meeting on February 27, 2026, all ten director nominees were elected and four proposals passed, including ratification of KPMG LLP as auditors for FY ending September 27, 2026 (87% support), advisory approval of executive compensation, amendment to the 2023 Omnibus Incentive Plan to increase shares available (62% support), and ratification of the Stockholder Protection Rights Agreement extending it to July 1, 2028. However, significant shareholder opposition was evident, with say-on-pay receiving only 65% support, the incentive plan amendment 62%, the Rights Agreement 70%, and director David Goebel facing a near-split vote (46% for vs 46% against).

• ·All director elections used plurality voting, allowing election despite opposition (e.g., David Goebel: 7,171,171 For, 7,010,617 Against, 1,213,528 Abstain)
• ·Broker non-votes: 561,088 across proposals 3-5

04-03-2026

For the three months ended January 31, 2026, Highwater Ethanol reported revenues of $34.4M, up 3.6% YoY from $33.2M, driven by strong 27% growth in corn oil sales to $3.3M, while modified distillers grains sales declined 8% to $1.5M and dried distillers grains remained flat at $3.8M. Gross profit surged to $3.5M from $1.0M YoY due to lower COGS, yielding operating income of $2.1M versus a prior loss, but net income fell to $5.6M from $8.3k primarily due to timing of $3.3M tax credits. Cash and total assets declined QoQ to $19.8M and $87.4M, respectively, amid $6.7M member distributions.

• ·Operating expenses increased to $1.4M from $1.3M YoY.
• ·Net cash provided by operating activities was $4.3M versus $(9.7M) YoY.
• ·Capital expenditures of $1.4M in the quarter.
• ·Distributions declared per unit: $1,400 (2026) vs $1,700 (2025).
• ·Net income per unit: $1,180.54 (2026) vs $1.75 (2025).

04-03-2026

First Financial Corp (THFF) reported 2025 net income of $79.2M, up 67.5% YoY from $47.3M, fueled by 25.6% growth in net interest income to $219.9M and a reduced provision for credit losses to $8.2M from $16.2M. However, deposits declined 3.6% YoY to $4.55B amid rising borrowings to $480.7M, non-interest expenses increased 7.3% to $154.9M, and securities holdings fell to $1.15B. Total assets grew 3.6% to $5.76B, loans expanded 5.7% to $4.06B, ROE rose to 13.3% from 8.8%, and cash dividends increased to $2.04 per share.

• ·Securities declined to $1.15B from $1.20B YoY.
• ·Non-interest income slightly down to $42.0M from $42.8M.
• ·Cash dividends declared per share increased quarterly, reaching $0.56 in Q4 2025 from $0.51 in Q4 2024.
• ·Stock price high reached $61.25 in Q4 2025, up from $50.61 in Q4 2024.

04-03-2026

UNL's net asset value per share declined 9.6% YoY to $7.34 at December 31, 2025, from $8.12, amid a 20.9% drop in average daily total net assets to $14.3M and ongoing net loss of $971k (narrowed 20% from $1.2M in 2024). While Partners’ Capital remained stable at $18.7M with slight 0.2% growth, total assets fell 1.2% to $18.8M and dividend/interest income decreased 35% to $586k with yield down to 4.09%. Commodity futures trading showed mixed results with $1.86M realized gains but $3.19M unrealized losses.

• ·Unrealized loss on open commodity futures contracts: $(2.07M) at Dec 31 2025 vs gain $1.12M at Dec 31 2024.
• ·Realized gain on closed commodity futures: $1.86M in 2025 vs loss $(7.41M) in 2024.
• ·Net cash from operating activities: $1.95M in 2025 vs $(6.33M) in 2024.
• ·Tax risk: Potential reallocation of income/gain items by IRS could make UNL liable for federal income tax.

04-03-2026

Oil States International, Inc. (OIS) reported FY2025 revenues of $669M, down 3.4% YoY from $693M, driven by an 8.4% increase in Products to $436M but a 19.8% decline in Services to $233M; Offshore Manufactured Products grew 8.3% to $431M with operating income up 6% to $69M, while Completion and Production Services fell 30% but swung to $4M profit from a $23M loss. The company posted a net loss of $109M versus $11M in 2024, primarily due to $100M in impairments (up from $25M) leading to an operating loss of $98M, though operating cash flow rose 129% to $105M and long-term debt dropped to $1.7M from $125M.

• ·Total assets declined to $883M from $1,005M YoY.
• ·Stockholders’ equity fell to $573M from $681M, impacted by $109M net loss and $17M stock repurchases.
• ·Inventory impairment of $21M in FY2025.
• ·Treasury stock purchases totaled $17M in FY2025.

04-03-2026

Voya Credit Income Fund (CIF) has issued a proxy statement for a special virtual shareholder meeting on May 19, 2026, at 1:00 p.m. (MST), seeking approval to amend its fundamental investment restriction to permit purchasing, selling, or holding real estate and commodities to the extent allowed by law, providing greater investment flexibility. The Board unanimously approved the proposal on January 22, 2026, and recommends voting FOR; shareholders of record as of February 23, 2026, are eligible to vote, with proxies due by May 18, 2026. No financial performance data or period comparisons are provided in the filing.

• ·Meeting held virtually only at https://www.viewproxy.com/voyafunds/broadridgevsm/; physical attendance not possible
• ·Voting methods: Internet (www.proxyvote.com/voya), telephone, mail, or virtually at meeting
• ·Solicitor contact for questions: 1-888-290-2487
• ·Fund address: 7337 East Doubletree Ranch Road, Suite 100, Scottsdale, Arizona 85258-2034; Phone: 1-800-992-0180

04-03-2026

Daktronics reported Q3 FY26 net sales of $181.9M, up 21.7% YoY from $149.5M, and 9M sales of $630.1M, up 8.0% YoY from $583.9M, driving operating income of $1.9M in Q3 (vs $3.6M loss) and $46.8M in 9M (up 34.1% YoY), with net income of $3.0M and $37.0M respectively (vs losses). However, cash from operations fell 27.4% YoY to $54.3M for 9M due to unfavorable working capital changes, while inventories dipped slightly to $103.6M from $105.8M YoY and the company spent $22.8M on share repurchases. Total assets grew to $546.4M from $502.9M at FY25 end.

• ·Treasury stock at cost increased to $(62.5M) from $(39.8M) at FY25 end due to repurchases.
• ·Accounts receivable, net rose to $114.3M from $92.8M at FY25 end.
• ·Stockholders' equity grew to $293.7M from $271.9M at FY25 end.

04-03-2026

RemSleep Holdings Inc. (RMSL) reported the passing of founder Thomas Wood, its Chairman and CEO, on February 26, 2026, creating vacancies in those roles. Effective March 2, 2026, Anita Michaels was elected Chairman of the Board, Jeffrey Marshall was appointed CEO and Director with an employment agreement including up to 7% equity incentives, and Alexander Johnson was appointed Director. The transition emphasizes continuity with Michaels retaining interim financial oversight amid no immediate financial disruptions noted.

• ·Anita Michaels, 72, is Thomas Wood's sister and inherited his ownership including super voting preferred shares.
• ·Jeffrey Marshall, 48, founder of HPM Marketing LLC, will continue limited outside consulting.
• ·Alexander Johnson, 52, previously consulted for the Company on capital formation and governance.

04-03-2026

Aimfinity Investment Corp. I, a blank check company, issued a promissory note for $500 to its CEO I-Fa Chang on February 28, 2026, to fund operations ahead of its pending business combination with Docter, Inc., originally agreed on October 13, 2023, and approved by shareholders on March 27, 2025. The note is payable upon closing of the business combination or company expiry and convertible into PubCo ordinary shares at $10.00 per share. A press release announcing a 'New Extension' was issued on March 3, 2026, as part of ongoing M&A communications.

• ·Promissory note maturity date: upon business combination closing or company expiry
• ·Note conversion price: $10.00 per PubCo ordinary share
• ·Merger agreement date: October 13, 2023
• ·Shareholder approval date: March 27, 2025
• ·Final Prospectus filing date: March 6, 2025

04-03-2026

Bankwell Financial Group, Inc. reported strong recovery in 2025 with net income surging 260% YoY to $35.2M from $9.8M in 2024, fueled by net interest income growth of 19% to $98.9M, total revenue up 25% to $108.3M, and provision for credit losses dropping sharply to $1.0M from $22.6M. Asset quality improved markedly with nonperforming assets to total assets at 0.49% versus 1.88% in 2024, and return on average assets rose to 1.09% from 0.31%. However, noninterest expenses increased 15% YoY to $58.8M due to higher salaries and professional services, while efficiency ratio improved modestly to 54.1% from 57.9%.

• ·Provision for credit losses declined to $1.0M in 2025 from $22.6M in 2024.
• ·Net (recoveries) charge-offs to average loans at -0.01% in 2025 vs 0.81% in 2024.
• ·Tier 1 capital to risk-weighted assets for Bankwell Bank at 11.87% in 2025 (up from 11.64%).
• ·Gains and fees from sales of loans jumped to $5.1M in 2025 from $0.5M in 2024.

04-03-2026

MYR Group Inc. filed its DEF 14A Proxy Statement on March 4, 2026, for the virtual 2026 Annual Meeting of Shareholders on April 23, 2026, at 8:00 a.m. Mountain Time, with a record date of February 27, 2026. Shareholders will vote on electing eight director nominees for one-year terms, advisory approval of named executive officer compensation, and ratification of the independent registered public accounting firm. The statement includes sections on corporate governance, director nominees, executive compensation discussion and analysis, pay versus performance, and audit matters.

• ·Virtual meeting accessible at virtualshareholdermeeting.com/MYRG2026; opens at 7:45 a.m. Mountain Time.
• ·Shareholders of record as of February 27, 2026, entitled to vote.
• ·Proxy materials available at investor.myrgroup.com/financial-information/annual-reports and proxyvote.com.
• ·Includes Pay Versus Performance disclosure and compensation data for years 2021-2025 for PEO (Swartz) and average Non-PEO NEOs (Johnson, Cooper, Fry, Waneka).
• ·2025 Annual Report on Form 10-K referenced.

04-03-2026

On March 2, 2026, Alignment Healthcare, Inc. entered into an underwriting agreement with J.P. Morgan Securities LLC and a selling stockholder for the underwritten offering of 13,167,733 shares of the Company's common stock. The offering closed on March 4, 2026, pursuant to a Registration Statement on Form S-3ASR (File No. 333-293928) filed that day, with the Company receiving no proceeds from the sale. The agreement includes customary representations, warranties, covenants, and indemnification obligations.

• ·Registration Statement File No. 333-293928 filed March 2, 2026
• ·Common stock par value $0.001 per share, traded as ALHC on NASDAQ

04-03-2026

Smith Micro reported Q4 FY2025 revenue of $4.0M, down 20% YoY from $5.0M, and FY2025 revenue of $17.4M, down 16% YoY from $20.6M, with gross margins improving slightly to 76.4% and 74.1% respectively. GAAP net losses narrowed to $4.7M ($0.20/share) in Q4 from $4.4M ($0.25/share) and to $30.1M ($1.46/share) for FY from $48.7M ($3.94/share), with non-GAAP losses also improving. William W. Smith Jr. is transitioning to Executive Chairman at month-end, with Tim Huffmyer becoming President and CEO, supported by $4M funding from Smith and his wife.

• ·Total assets declined to $25.0M as of Dec 31, 2025 from $48.0M as of Dec 31, 2024.
• ·Goodwill fully impaired to $0 as of Dec 31, 2025 from $11.1M as of Dec 31, 2024.
• ·Accounts receivable net declined to $1.8M as of Dec 31, 2025 from $5.7M as of Dec 31, 2024.
• ·Reverse stock split (1-for-8) effective April 10, 2024.
• ·Investor conference call on March 4, 2026 at 4:30 p.m. ET.

04-03-2026

BillionToOne reported Q4 2025 total revenue of $96.1M, up 113% YoY from $45.1M, and full year 2025 revenue of $305.1M, up 100% YoY from $152.6M, driven by prenatal revenue growth of 99% in Q4 and 90% FY, and oncology surging 735% in Q4 and 748% FY. However, Clinical Trial Support and Other Services revenue declined 18% FY YoY to $3.1M, while operating expenses rose 56% in Q4 and 50% FY. The company achieved Q4 operating income of $10.3M (vs. $11.7M loss prior) and FY operating income of $16.0M (vs. $47.1M loss), raised 2026 revenue guidance to $430M-$445M (41-46% growth), and holds $496M in cash.

• ·Gross profit Q4 2025: $68.6M (71% margin) vs. $25.7M (57% margin) Q4 2024.
• ·FY 2025 gross margin: 68% vs. 53% in 2024.
• ·Q4 2025 net income available to common shareholders: $4.4M ($0.11 per diluted share) vs. net loss $11.5M ($1.13 per diluted share).
• ·FY 2025 net cash flow excluding IPO proceeds: $12.5M.
• ·Overall ASP Q4 2025: $561 vs. $382 Q4 2024 (+47%).
• ·New products launched: Red Blood Cell and Platelet Fetal Antigen NIPT in Feb 2026; Northstar PGx and Northstar Select CH in Q1 2026.
• ·Conference call: March 4, 2026 at 1:30pm PT / 4:30pm ET.

04-03-2026

Verastem, Inc. reported total revenue of $30.9M for the year ended December 31, 2025, driven by $30.9M in new product revenue, up significantly from $10M in 2024 from the COPIKTRA license sale to Secura. However, operating expenses increased 61% YoY to $201M, with R&D up 41% to $114.6M and SG&A surging 86% to $81.1M, leading to a widened net loss of $209.5M from $130.5M in 2024. The company highlighted risks including regulatory approval delays, commercialization challenges, and potential impacts on milestone payments and royalties from Secura.

• ·Optional third tranche purchase of up to $50M Notes available prior to December 31, 2026, contingent on trailing six-month net sales of avutometinib and defactinib reaching at least $55M.
• ·Cost of sales - product: $4.6M in 2025; Cost of sales - intangible amortization: $0.7M in 2025.
• ·Loss from operations worsened to $(170.1M) in 2025 from $(115.0M) in 2024.

04-03-2026

Insulet Corporation entered into a severance agreement and release with its former Chief Financial Officer, Ana M. Chadwick, on February 27, 2026. The agreement implements previously disclosed severance and post-termination benefits without any material changes or additional compensation terms. The filing was made on March 4, 2026, signed by Patricia K. Dolan, Vice President and Secretary.

• ·Severance Agreement references Company's Form 8-K filed September 16, 2025, Amended and Restated Executive Severance Plan filed April 28, 2025, and Confidentiality, Non-Solicit, Non-Compete, and IP Assignment Agreement dated April 7, 2024.
• ·Includes standard provisions for release of claims, mutual non-disparagement, and compliance with prior agreements.

04-03-2026

Horizon Bancorp, Inc. announced the elimination of the Chief Administration Officer position at the company and its subsidiary Horizon Bank, effective March 31, 2026, leading to the departure of Mark E. Secor, Executive Vice President and Chief Administration Officer, to pursue other opportunities. The departure is not related to any disagreement on financial, accounting, or other matters. In connection, the company expects to provide Mr. Secor with severance of one week of pay per full year of service (maximum 13 weeks) based on his then-current weekly rate, plus a pro-rated 2026 Executive Officer Bonus at target, subject to a seven-day revocation period.

• ·Announcement made on March 3, 2026
• ·SEC filing dated March 4, 2026
• ·Includes customary general release of claims, non-disclosure, non-disparagement, and confidentiality covenants

04-03-2026

Grocery Outlet Holding Corp. reported FY ended January 3, 2026 net sales of $4.69B, up 7.3% YoY from $4.37B, with gross profit rising 7.4% to $1.42B and adjusted EBITDA improving to $254M from $237M. However, the company recorded an operating loss of $222M versus prior-year income of $78M, net loss of $225M versus $39M profit, driven by $149M goodwill impairment, $114M long-lived assets impairment, restructuring charges up 189% to $46M, and SG&A expenses up 8.5%; comparable store sales increased only 0.5% (flat, down from 2.7%). Store count reached 570, up from 533, but new stores opened fell to 42 from 67.

• ·GAAP diluted EPS: $(2.30) vs $0.40 prior year; Adjusted diluted EPS flat at $0.76 vs $0.77.
• ·EBITDA: $(91M) vs $187M prior year.
• ·Adjusted net income: $75M vs $76M prior year (flat).

04-03-2026

Brown-Forman reported nine-month net income of $661M, down 9% YoY from $723M, with three-month net income also slightly declining 1% to $267M from $270M; diluted EPS for nine months fell 8% to $1.41 from $1.53. However, operating cash flow surged 59% YoY to $709M from $446M, comprehensive income rose to $793M for nine months, and total assets grew 3% sequentially to $8.3B as of January 31, 2026. The company repurchased $400M in treasury stock, contributing to lower cash of $383M, while restructuring charges decreased to $19M for nine months.

• ·Restructuring charges for nine months ended Jan 31, 2026 totaled $19M, down from $33M prior year.
• ·Proceeds from sale of equity method investment $350M in prior nine months; none in current.
• ·Total inventories increased to $2,560M as of Jan 31, 2026 from $2,511M.
• ·Goodwill increased to $1,536M from $1,505M due to foreign currency translation.
• ·Other intangible assets net $1,088M as of Jan 31, 2026, up from $981M.

04-03-2026

Emmaus Life Sciences, Inc. entered into an Exclusive Supply Agreement with NeoImmuneTech, Inc. on March 2, 2026, as contemplated by the prior License and Exclusive Distribution Agreement dated December 24, 2025, granting NIT exclusive rights to market, sell, and distribute Endari® and generic equivalents for sickle cell disease in the U.S., its territories, and Canada. Under the Supply Agreement, Emmaus will exclusively supply the products to NIT at cost plus a specified double-digit percentage margin, subject to the License Agreement's Effective Date. However, the Effective Date depends on NIT obtaining necessary regulatory approvals and other conditions, with no assurance of occurrence and potential termination by either party if not achieved by October 1, 2026.

• ·License Agreement previously reported in 8-K filed December 31, 2025
• ·Field: sickle cell disease
• ·Territory: U.S. and its territories/possessions, Canada
• ·Full agreements to be filed as exhibits to 10-K for year ended December 31, 2025 and 10-Q for three months ended March 31, 2026

04-03-2026

On March 3, 2026, a subsidiary of SITE Centers Corp. completed the sale of its interests in the property located at 3030 North Broadway (Chicago, Illinois) to L3 3030 Broadway LLC for $50.1 million in cash. The transaction is subject to customary adjustments for closing pro-rations, allocations, and credits. No additional financial metrics, comparisons, or impacts were disclosed.

04-03-2026

Applied Digital Corporation entered into an unconditional guarantee effective February 26, 2026, backing the full performance obligations of its subsidiary Base Electron, Inc. under a Design-Build Agreement with The Babcock & Wilcox Company. The guarantee covers both monetary and non-monetary obligations, remains in effect until all obligations are discharged, and includes waivers of typical surety defenses. No specific financial amounts or terms of the underlying Design-Build Agreement were disclosed.

• ·Guarantee governed by Texas law with exclusive jurisdiction in Texas courts.
• ·Payments under guarantee due within 30 days of written demand.
• ·Notice addresses: Applied Digital at 3811 Turtle Creek Blvd., Suite 2100, Dallas, TX 75219; Babcock & Wilcox at 1200 East Market Street, Suite 650, Akron, OH 44305.

04-03-2026

BrightSpring Health Services, Inc. entered into an underwriting agreement on March 2, 2026, with Goldman Sachs & Co. LLC for the secondary offering of 20,000,000 shares of common stock by selling stockholders KKR Phoenix Aggregator L.P. and Management Selling Stockholders at $41.15 per share (totaling $823M), with closing on March 4, 2026. The company repurchased 1,464,807 shares from the underwriter as part of the offering and received no proceeds except from cash exercises of stock options by management sellers. No underwriting fees were paid on the repurchased shares.

• ·Underwriting agreement filed as Exhibit 1.1
• ·Registration statement on Form S-3ASR (File No. 333-287916) filed June 10, 2025
• ·Preliminary prospectus supplement filed March 2, 2026; final March 3, 2026

04-03-2026

Hain Celestial Group (Nasdaq: HAIN) completed the sale of its North American Snacks business, including Garden Veggie Snacks™, Terra® chips, and Garden of Eatin'® snacks, to Snackruptors Inc. Proceeds from the transaction will be used to reduce debt, strengthening the company's financial position and leverage profile. The divestiture sharpens focus on higher-margin core categories such as yogurt, tea, and baby & kids foods, with retained global brands including Celestial Seasonings® teas, The Greek Gods® yogurt, Earth's Best® Organic, and Ella's Kitchen®.

• ·Headquartered in Hoboken, N.J.
• ·Products marketed and sold in over 70 countries.
• ·Filing Date: March 04, 2026; Announcement Date: March 2, 2026

04-03-2026

On February 26, 2026, Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement for a private placement, selling debentures with an aggregate principal amount of $200,000, bearing 0% interest and due April 27, 2026. The debentures are convertible into common stock upon consummation of a public offering at the offering price, subject to a 9.99% beneficial ownership limit, with potential issuance of warrants equal to 100-150% of related shares depending on timing. The transaction was consummated for $200,000 and exempt from registration under Section 4(a)(2) and Regulation D.

• ·Debentures maturity date: April 27, 2026, extendable by holder in 60-day increments.
• ·Warrants, if issued, exercisable immediately at Public Offering price, expire 5 years from issuance.
• ·Filing date: March 04, 2026; event date: February 26, 2026.

04-03-2026

Columbus McKinnon Corporation (CMCO) completed the acquisition of Kito Crosby Limited for $2.7B cash on February 3, 2026, funded primarily through new debt facilities ($1.65B Term Loan B, $500M Revolving Credit Facility with $75M drawn), $900M senior secured notes, and $800M preferred shares issuance. Concurrently, CMCO divested its U.S. power chain hoist and chain manufacturing operations (Divestiture Business) to Star Hoist Intermediate, LLC for $210M on March 4, 2026, with proceeds earmarked to repay a portion of the Term Loan B. Unaudited pro forma condensed combined financial information as of December 31, 2025, reflects these transactions but excludes integration costs, synergies, or divestiture transition services impacts.

• ·Stock Purchase Agreement entered February 10, 2025; acquisition closed February 3, 2026.
• ·Divestiture Equity Purchase Agreement entered January 13, 2026; closed March 4, 2026.
• ·Preferred Shares: 7.00% dividend rate, convertible at $37.68 per share.
• ·Term Loan B matures 7 years post-closing; Revolving Credit Facility matures 5 years post-closing.
• ·Pro forma adjustments preliminary; subject to final fair value determination and potential material changes.
• ·Divestiture not classified as discontinued operations.

04-03-2026

Innoviz Technologies Ltd. reported FY2025 revenues of $55.1M, surging 127% YoY from $24.3M, with gross profit turning positive at $12.9M (23% margin) versus a $1.2M gross loss (-5% margin) in 2024; operating expenses fell 20% to $80.6M from $100.8M, narrowing the operating loss to $67.7M and net loss to $67.8M ($0.34/share) from $101.9M and $94.8M ($0.57/share), respectively. However, R&D expenses remained high at $56.5M (down 23% YoY but still substantial), and the company warns that ongoing heavy R&D investments and costly strategic initiatives to expand inside/outside automotive may further pressure profitability without sufficient revenue growth.

• ·Filing date: March 04, 2026
• ·Sales and marketing expenses declined to $5.8M from $7.5M YoY
• ·General and administrative expenses declined to $18.4M from $19.5M YoY
• ·Financial income net dropped sharply to $0.1M from $7.3M

04-03-2026

National Presto Industries reported 2025 net sales of $503.5M, up 29.7% YoY from $388.2M, primarily driven by a 42.9% increase ($121.9M) in Defense segment sales from higher backlog shipments, which also boosted Defense operating earnings 36.2% ($15.5M). However, net earnings fell 20.2% to $33.1M ($4.63 per share) from $41.5M ($5.82 per share), due to Housewares/Small Appliance segment sales declining 7.0% ($7.2M) and operating losses from Trump tariffs, distribution center relocation, and supplier bankruptcy. The Board declared a regular 2026 dividend of $1.00 per share with no extra dividend, while Safety segment showed modestly increased sales but still nominal with a reduced loss.

• ·Dividend record date: March 9, 2026; payment date: March 20, 2026
• ·82-year unbroken dividend history
• ·2026 annual shareholder meeting: May 19, 2026 (record date March 24, 2026)
• ·Safety segment: increased sales (nominal) and reduced comparative loss
• ·Tariffs treated as period costs under LIFO inventory method

04-03-2026

Keros Therapeutics reported total revenue of $244M for the year ended December 31, 2025, surging 6,772% YoY from $3.6M, primarily from $205M in license revenue and $39M in service revenue, leading to net income of $87M versus a $187M loss in 2024 and positive operating cash flow of $108M versus a $161M outflow. R&D expenses declined 25% to $130M while G&A rose 15% to $47M. However, cash and equivalents fell 49% to $287M from $560M, total assets dropped 45% to $338M from $616M, and stockholders' equity decreased 47% to $303M, driven by a $385M repurchase of 21.1M treasury shares that halved outstanding shares to 19.5M.

• ·EPS basic $2.34 in 2025 vs ($5.00) in 2024.
• ·Net cash used in financing activities ($378M) in 2025 vs provided by $392M in 2024 due to no issuances and $375M repurchase.
• ·Stock-based compensation expense $29M in 2025 vs $35M in 2024.
• ·Income tax provision $4.9M in 2025 vs $0.3M in 2024.
• ·Cash paid for taxes $7.1M in 2025.

04-03-2026

Resources Connection, Inc. (RGP) entered into a Separation and General Release Agreement with Chief Operating Officer Bhadreskumar Patel on March 3, 2026, with his last day of employment set for May 15, 2026. Patel will continue receiving his current salary through the separation date and is eligible for severance including a $1.65M lump sum (1.5x base salary plus target bonus), COBRA cost approximation for 18 months, and accelerated vesting of all unvested equity awards. The company does not plan to appoint a replacement COO, with business unit Presidents reporting directly to CEO Roger Carlile thereafter.

• ·Separation Agreement provides full term to exercise outstanding stock options
• ·Original Employment Agreement dated April 3, 2024
• ·Performance-based RSUs to vest at target level

04-03-2026

SCYNEXIS INC reported total revenue of $20.6M for the year ended December 31, 2025, surging 449.9% YoY from $3.7M, driven by $1.4M in new product revenue and license agreement revenue up 411.4% to $19.2M. Operating expenses declined 10.2% to $36.7M, narrowing the net loss 59.6% to $8.6M from $21.3M; however, total assets contracted to $59.0M from $90.6M, short-term investments fell to $18.8M from $43.2M, and stockholders' equity decreased to $49.4M from $55.1M.

• ·Net cash used in operating activities improved to $(5.3M) in 2025 from $(24.0M) in 2024.
• ·Net cash provided by investing activities was $24.3M in 2025 vs $6.2M in 2024.
• ·Weighted average common shares outstanding basic and diluted: 49,933,381 in 2025 vs 48,513,073 in 2024.
• ·Stock-based compensation expense: $2.9M in 2025 vs $3.3M in 2024.

04-03-2026

Niagen Bioscience, Inc. reported total net sales of $129.4M for the year ended December 31, 2025, up 30% YoY from $99.6M, driven by strong growth in Consumer Products (+27%) and Ingredients (+45%). However, the Analytical Reference Standards and Services segment showed flat growth of only 2% YoY. Net income increased to $17.4M from $8.6M, supported by gross profit growth of 35% to $83.2M and a gain on settlement of royalty obligation, though general and administrative expenses rose significantly to $27.1M from $18.4M.

• ·Basic EPS increased to $0.22 from $0.11 YoY.
• ·Diluted EPS increased to $0.20 from $0.11 YoY.
• ·Sales and marketing expenses rose 20% to $35.5M from $29.5M.
• ·Research and development expenses increased slightly to $6.3M from $6.0M.
• ·Interest income, net rose to $2.1M from $1.1M.
• ·IRS ERTC disallowance of $0.2M in 2025.
• ·Provision for income taxes $0.8M in 2025 vs $0.3M in 2024.

04-03-2026

Crane Harbor Acquisition Corp. II, a blank check company, made available its PFIC Annual Statement for Class A ordinary shares on March 4, 2026, covering the tax period from June 19, 2025, to December 31, 2025, to enable shareholders to make a QEF Election. The statement reports minimal ordinary earnings of $0.0010103085 per unit per day, no net capital gains, and no cash or property distributions. No other financial activity or changes were disclosed.

• ·PFIC status for U.S. federal income tax purposes; QEF Election optional for shareholders
• ·Net Capital Gains: NONE
• ·Distributions: Cash NONE; Fair Market Value of Property: NONE
• ·Date of Incorporation: 6/19/2025
• ·EIN: 98-1868608
• ·Class A ordinary shares par value: $0.0001 per share

04-03-2026

Oculis Holding AG reported a widened net loss of $99M for the year ended December 31, 2025, up 15.4% YoY from $86M in 2024, driven by higher R&D expenses (up 9.6% to $57M) and G&A expenses (up 18.2% to $26M), along with a deteriorated finance result. However, grant income grew 74.8% YoY to $1.2M, cash and cash equivalents rose to $81M from $28M, total assets doubled to $236M from $120M, and net cash increased by $60M supported by $187M in financing inflows (up 246.3% YoY). Operating cash outflow worsened to $66M (up 35.5% in magnitude), while investing outflows surged 278.9% to $61M.

• ·Amended and Restated Loan Agreement with Kreos Capital dated July 31, 2025.
• ·Sales Agreement with Leerink Partners dated May 8, 2024.
• ·Share-based compensation within R&D: $9M in 2025 (up 78.9% YoY); within G&A: $7M (up 48.2% YoY).
• ·Warrant liabilities decreased to $14M from $20M as of Dec 31, 2025.

04-03-2026

On March 4, 2026, the Board of Directors of Vir Biotechnology, Inc. appointed Marianne De Backer, M.Sc., Ph.D., MBA, the company's Chief Executive Officer and principal executive officer, to the additional position of President. There are no arrangements or understandings with other persons regarding the appointment, no family relationships with directors or executive officers, and no direct or indirect interests in transactions requiring disclosure under Item 404(a) of Regulation S-K. Biographical information for Dr. De Backer is incorporated by reference from the company's definitive proxy statement filed on April 17, 2025.

04-03-2026

PennantPark Floating Rate Capital Ltd. entered into a Second Supplemental Indenture with Equiniti Trust Company, LLC, for the issuance of $200M aggregate principal amount of 6.75% notes due 2029, generating net proceeds of approximately $195.9M after underwriting discounts and expenses. The Company intends to use the proceeds to repay outstanding indebtedness under its multi-currency senior secured revolving credit facility with Truist Bank and other lenders, invest in portfolio companies, and for general corporate purposes. The notes are general unsecured obligations, ranking pari passu with existing unsecured debt but effectively subordinated to secured indebtedness.

• ·Notes mature on March 4, 2029, with interest payable semi-annually on March 4 and September 4, commencing September 4, 2026.
• ·Base Indenture dated March 23, 2021; credit facility initially entered August 12, 2021.
• ·Indenture includes covenants for compliance with Investment Company Act asset coverage requirements and change of control repurchase at 100% principal plus accrued interest.
• ·Notes offered under Registration Statement on Form N-2 (File No. 333-279726); prospectus supplements dated February 25, 2026.

04-03-2026

Sight Sciences, Inc. (SGHT) reported FY2025 revenue of $77.4M, down 3.1% YoY from $79.9M, with Interventional Glaucoma nearly flat at -0.2% ($75.7M) but Interventional Dry Eye plunging 58.7% to $1.6M. While gross margins improved slightly to 86.2% and operating expenses fell 12.7% to $103.8M, leading to a narrowed net loss of $38.4M (improved 25.4% YoY), cash and equivalents dropped to $92.0M from $120.4M due to higher operating cash burn of $29.7M.

• ·Total assets declined to $115.3M from $142.8M as of Dec 31, 2025 vs 2024.
• ·Stockholders’ equity decreased to $63.9M from $87.5M.
• ·Long-term debt increased slightly to $40.3M from $39.4M.
• ·Stock-based compensation expense fell to $13.1M from $17.1M.

04-03-2026

Sabre GLBL Inc., a wholly owned subsidiary of Sabre Corporation, completed the redemption of all $91.6M aggregate principal amount of its 8.625% Senior Secured Notes due 2027 on March 1, 2026, at a redemption price of 102.156% of the principal plus accrued and unpaid interest. This redemption, as previously announced on December 23, 2025, terminates the related Indenture dated September 7, 2023, with Computershare Trust Company, N.A. as trustee.

• ·Indenture dated September 7, 2023
• ·Redemption notice provided December 23, 2025

04-03-2026

Costamare Inc. discloses its containership fleet in its 20-F annual report filed on March 04, 2026, consisting of 69 operating vessels with capacities ranging from 1,078 to 14,424 TEU and charter expirations from October 2026 to March 2036, primarily with charterers like Evergreen, MSC, COSCO, and Maersk. Average daily charter rates are provided for select vessels, such as $40,613 for the 14,424 TEU TRITON and $34,881 for the 9,469 TEU SHANGHAI, with TEU-weighted durations up to 6.9 years. Additionally, 10 newbuildings of 3,100 TEU each are under construction, with deliveries scheduled from Q2 2027 to Q4 2028 and employment secured upon delivery.

• ·Largest vessels: Five 14,424 TEU ships (TRITON, TITAN, TALOS, TAURUS, THESEUS) chartered to Evergreen, expiring 2036.
• ·Earliest charter expirations: October 2026 (MAERSK PUELO, ARKADIA), with some extendable.
• ·Many charter details confidential (marked with *) including rates and exact expirations.
• ·Newbuilding deliveries: Q2-Q4 2027 (4 vessels), Q1-Q4 2028 (6 vessels), with long-term or medium-term employment.

04-03-2026

H2O America (NASDAQ: HTO) announced a proposed underwritten public offering of $550M in common stock, consisting of $150M direct issuance by the company and $400M via forward sale agreements with JPMorgan and Wells Fargo affiliates, with a 30-day underwriter option for up to $82.5M additional shares. Net proceeds, along with debt financing, are intended primarily to fund the Quadvest Acquisition and related expenses, or for general corporate purposes if the acquisition does not close, as the offering is not conditioned on it. The announcement highlights no immediate financial metrics but notes risks including regulatory approvals and integration challenges for the acquisition.

• ·Announcement date: March 2, 2026
• ·Filing date: March 4, 2026
• ·Forward sale agreements settlement by March 2, 2028 at company's discretion
• ·Underwriter option period: 30 days
• ·Operates across approximately 409,000 water and wastewater service connections serving 1.6 million people

04-03-2026

COMPX International Inc reported net sales of $158.3M for 2025, up 8% from $145.9M in 2024 but still below 2023's $161.3M after a 10% YoY decline the prior year. Operating income rebounded 33% YoY to $22.6M (14.3% of sales) from $17.0M, with gross margin improving 16% to $48.2M (30.4%), however operating costs rose 5% to $25.6M and remained elevated at 16.2% of sales compared to 2023 levels.

• ·Goodwill of $23.7M at Dec 31, 2025, all related to Security Products reporting unit; tested annually in Q3 or upon triggering events.
• ·Net book value of property and equipment $23.7M at Dec 31, 2025; assessed for impairment based on future cash flows when indicators exist.
• ·Cost of sales $110.1M in 2025 (69.6% of sales), up 5% from $104.6M in 2024.

04-03-2026

Orion Group Holdings Inc reported contract revenues of $852.3M for FY2025, up 7% YoY from $796.4M, driven by growth in state/local governments (+57% and +29%) and private companies (+13%), though federal government revenues declined 30% YoY. Gross profit rose 16% to $105.6M and operating income increased 27% to $14.6M, with Marine segment revenues up 5% and operating income surging to $29.9M from $2.3M; however, Concrete segment posted an operating loss of $15.3M versus $9.2M profit prior year despite 12% revenue growth, and cash equivalents dropped sharply to $1.6M from $28.3M amid high capital expenditures of $38.9M.

• ·Net income turned positive at $2.5M in FY2025 from $1.6M loss in FY2024 and $17.9M loss in FY2023.
• ·Interest expense declined 34% YoY to $8.9M from $13.4M.
• ·Long-term debt reduced to $6.1M from $22.8M at year-end.
• ·Basic EPS improved to $0.06 from $(0.05).

04-03-2026

NN Inc reported net sales of $422.2M for FY 2025, down 9.1% YoY from $464.3M, while net loss narrowed to $34.0M from $38.3M, an 11.2% improvement driven by lower cost of sales and depreciation. Operating loss improved to $18.9M from $27.5M; however, Mobile Solutions segment sales declined 14.1% to $244.0M with persistent losses, while the other segment (likely Life Sciences) saw nearly flat sales (-1.1% to $178.6M) but operating income fell 21.3% to $10.3M. Total assets decreased to $440.8M from $456.9M, with long-term debt at $153.8M.

• ·Depreciation and amortization declined 20.7% YoY to $35.9M from $45.3M.
• ·Share of net income from joint venture flat at 2.1% of sales but absolute value down 7.3% to $8.9M.
• ·Basic and diluted net loss per share improved to $(1.07) from $(1.11).
• ·Cash and cash equivalents down to $11.4M from $18.1M; inventories up 6.6% to $66.0M.

04-03-2026

Stevanato Group S.p.A. reported FY2025 revenue of €1,186.3 million, up 7.4% YoY from €1,104.0 million, driven by 11.2% growth in Biopharmaceutical and Diagnostic Solutions to €1,038.2 million (with high-value solutions surging 29.4%), while gross profit rose 13.7% to €343.9 million and operating profit increased 23.4% to €198.8 million. However, the Engineering segment revenue declined 21.4% to €281.0 million from €357.6 million, with its gross margin dropping to 11.0% from 15.7% and operating margin falling to 3.3% from 9.3%; additionally, revenue from other containment and delivery solutions decreased 3.8% to €491.8 million. Net profit attributable to equity holders grew 18.7% to €139.8 million, with total headcount at 6,010 as of December 31, 2025.

• ·Dividend approved per share €0.054 (up 1.9% YoY), equivalent to $0.061 (up 7.0% YoY).
• ·Basic and diluted EPS €0.51 (up 17.9% YoY from €0.43).
• ·R&D expenses declined 19.7% to €25.4 million.
• ·Finance expense increased 58.0% to €22.7 million.
• ·Total liabilities up €133.1 million to €1,057.5 million.

04-03-2026

PepGen Inc. reported a slightly narrower net loss of $89.7M for the year ended December 31, 2025, compared to $90.0M in 2024, with operating expenses declining 4.2% YoY to $93.6M driven by a 7.1% drop in R&D expenses, though G&A rose 6.2%. Cash and equivalents grew 22.5% to $60.5M, bolstered by $108M net proceeds from a public offering, resulting in a net cash increase of $11.1M versus a $31.4M decrease prior year; however, interest income fell 43.7% to $4.0M and shares outstanding more than doubled to 68.9M, diluting EPS to $(2.12) from $(2.85). Total assets expanded 15.3% to $173.9M, but accumulated deficit widened to $361.1M.

• ·Stock-based compensation expense declined to $10.6M from $11.5M YoY.
• ·Net cash used in investing activities improved to $(15.2M) from $(37.7M), with lower purchases of marketable securities.
• ·Accumulated deficit increased to $361.1M from $271.5M.
• ·Employment agreements executed with executives on May 20, 2025 (Kasra Kasrarian, PhD), August 19, 2024 (Paul D. Streck), and December 8, 2025 (Joseph Vittiglio).

04-03-2026

Farmer Brothers Coffee Co. (NASDAQ: FARM) will be acquired by Royal Cup Coffee & Tea for $1.29 per share in an all-cash transaction, creating a scaled, integrated beverage solutions platform with support from Braemont Capital. The deal has unanimous board approval and is expected to close by June 30, 2026, subject to shareholder approval and customary conditions, after which FARM will become private and delist from NASDAQ. No period-over-period financial metrics were disclosed in the announcement.

• ·Transaction expected to close in fiscal fourth quarter ending June 30, 2026.
• ·Farmer Brothers founded in 1912; Royal Cup nearly 130 years old (since 1896).
• ·Proxy statement to be filed with SEC; shareholders urged to read for details.

04-03-2026

On March 4, 2026, Charging Robotics Inc. entered into a securities purchase agreement with accredited investors for a private placement of 500,000 shares of common stock or pre-funded warrants at $4.00 per share or $3.9999 per pre-funded warrant, expecting approximately $2.0 million in gross proceeds before expenses. The transaction is expected to close upon the effectiveness of the company's uplisting to a national securities exchange, subject to customary conditions. A registration rights agreement requires filing a resale registration statement with the SEC within 30 days post-closing.

• ·Pre-Funded Warrants exercisable at $0.0001 per share and do not expire until fully exercised.
• ·Resale Registration Statement must be declared effective within 60 days (if not reviewed by SEC) or 90 days (if reviewed) after filing.
• ·Securities offered pursuant to Section 4(a)(2) of the Securities Act exemption.
• ·Company is an emerging growth company.

04-03-2026

Hess Midstream LP announced a $60M accretive repurchase, consisting of $18M (455,811 Class B units at $39.49 each) from a Chevron affiliate via its subsidiary Hess Midstream Operations LP, and $42M of Class A shares through an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank. The transactions, unanimously approved by the conflicts committee, are expected to boost distributable cash flow per Class A share, supporting at least 5% annual distribution growth through 2028, while preserving approximately $1B in financial flexibility. Funding will come from the existing revolving credit facility, with unit repurchase closing on March 4, 2026, and ASR settling in March 2026.

• ·Unit repurchase represents approximately 0.2% of the consolidated company.
• ·Post-unit repurchase (pre-ASR): ownership 62.2% public and 37.8% Chevron.
• ·ASR final shares based on volume-weighted average prices during term.
• ·Transactions unanimously approved by Board based on conflicts committee recommendation.

04-03-2026

On February 26, 2026, the Board of Directors of CoastalSouth Bancshares, Inc. appointed J. Simon Fraser as a director, effective immediately, with his term set to expire at the 2026 Annual Meeting of Stockholders, after which he is expected to join the Audit Committee and Nominating and Governance Committee. Mr. Fraser is determined to be an independent director under applicable SEC and NYSE standards. The appointment involves no arrangements with other persons, no family relationships, and only ordinary course loans from subsidiary Coastal States Bank.

• ·Loans to Mr. Fraser from Coastal States Bank were made in the ordinary course of business on substantially the same terms as comparable transactions with non-related persons, with no more than normal risk of collectability.
• ·No transactions between Mr. Fraser and the Company required to be reported under Item 404(a) of Regulation S-K, except the described loans.

04-03-2026

Crane Harbor Acquisition Corp., a blank check company, filed an 8-K on March 4, 2026, making available its PFIC Annual Statement for fiscal year 2025 (January 2 to December 31, 2025) to Class A ordinary shareholders to facilitate optional QEF elections. The statement discloses minimal ordinary earnings of $0.0011219650 per-unit per-day, with no net capital gains or distributions reported.

• ·Taxpayer Identification Number: 98-1830736
• ·Country of Incorporation: Cayman Islands
• ·Date of Incorporation: January 2, 2025
• ·Principal Address: 1845 Walnut Street, Suite 1111, Philadelphia, PA 19103

04-03-2026

Rigetti Computing's 2025 revenue declined 34% YoY to $7.1M from $10.8M, with gross profit dropping 64% to $2.1M despite a 1% reduction in cost of revenue. Operating expenses increased 17% to $86.7M, driven by 23% higher R&D, resulting in a widened operating loss of $84.7M (up 24%) and net loss of $216.2M (up 8% YoY). However, the balance sheet strengthened significantly, with total assets more than doubling to $666.6M from $284.8M, bolstered by $545.0M in short- and long-term investments and stockholders' equity rising to $546.2M.

• ·Cash and cash equivalents decreased to $44.9M from $67.7M as of Dec 31, 2025 vs 2024.
• ·Derivative warrant liabilities increased to $102.6M from $93.1M.
• ·Common stock shares outstanding rose to 331.3M from 283.5M.
• ·Available-for-sale investments (short-term + long-term) surged to $544.9M from $149.5M.

04-03-2026

CenterPoint Energy's 2026 Proxy Statement outlines 2025 governance updates, including September bylaws amendments aligning with Texas legislative changes (e.g., 3% ownership threshold for derivative suits, jury trial waiver, exclusive forum provisions) and an increase in director retirement age from 73 to 75 years for greater Board flexibility. In October 2025, the Board approved a combined Chair/CEO role for Jason Wells with Theodore O. Franklin as Lead Independent Director to enhance strategic execution amid a $65.5B ten-year capital plan, while maintaining 100% independent committees and 10 independent directors. No waivers of ethics codes or related-party transactions occurred in 2025, with majority voting for uncontested director elections.

• ·No waivers granted for Code of Ethics or Ethics and Compliance Code to executive officers or directors in 2025.
• ·No related-party transactions required to be reported under SEC rules since January 1, 2025.
• ·Majority voting standard applies to uncontested director elections; plurality for contested.
• ·Corporate Governance Guidelines, Bylaws, and related policies available at https://investors.centerpointenergy.com/governance.

04-03-2026

For the quarter ended January 30, 2026, Cracker Barrel reported revenue of $875M, down 7.9% YoY from $949M, with net income falling sharply to $1.3M from $22.2M amid higher impairments and weak operating income of $0.5M versus $29.1M prior year. Six-month revenue declined 6.8% YoY to $1.67B, swinging to a $23.3M net loss from $27.1M profit, though G&A expenses dropped 22% YoY to $48M in the quarter. Total assets decreased to $2.10B from $2.16B at fiscal year-end, with cash equivalents falling to $8.6M from $39.6M.

• ·Cash flows from operating activities for six months: -$2.2M vs $93.7M prior year.
• ·Long-term debt increased to $382M from $335M sequentially.
• ·Shareholders’ equity declined to $426M from $462M sequentially.
• ·Property and equipment capex six months: $62M vs $77M prior year.
• ·Dividends declared six months: $0.25 per share, total ~$12M.

04-03-2026

ASPAC III Acquisition Corp. reported net income of $1.34M for the year ended December 31, 2025, a turnaround from a $0.23M loss in 2024, driven by $2.17M in interest income (+502% YoY), though operating losses widened to $0.83M (+41% YoY) due to higher G&A (+40%) and legal expenses (+41%). However, the balance sheet deteriorated sharply with total assets falling 94% YoY to $3.94M from $62.08M, primarily due to massive redemptions reducing trust account investments by 95% to $2.98M and cash declining 45% to $0.87M, while shareholders' equity dropped 89% to $0.42M.

• ·Promissory note - related party: $0 as of Dec 31, 2025 (down from $276,221 as of Dec 31, 2024)
• ·Basic and diluted net income per redeemable Class A share: $0.47 (2025) vs $0.50 (2024)
• ·Basic and diluted net loss per non-redeemable Class A and B share: ($0.49) (2025) vs ($0.38) (2024)
• ·Up to 206,250 Class B shares subject to forfeiture related to underwriter over-allotment option

04-03-2026

Aquestive Therapeutics reported Q4 2025 total revenues of $13.0M, up 10% YoY from $11.9M, driven by manufacture and supply revenue growth to $12.0M, while FY 2025 revenues declined 3% to $44.5M excluding prior-year deferred revenue recognition, with manufacture and supply revenue flat at $40.2M. Net losses widened significantly to $31.9M in Q4 (incl. $13.6M one-time legal) and $83.8M for FY 2025 (incl. $14.3M one-time legal), versus $17.1M and $44.1M prior year, due to higher SG&A and commercial spending for Anaphylm launch prep; however, the company met 2025 guidance excluding one-time items and guides to $70M cash at end-FY2026. Pipeline updates include Anaphylm NDA resubmission targeted for Q3 2026 post-CRL, with RTW revenue sharing extended to June 30, 2027, a $5M share purchase commitment, and warrant for 375,000 shares.

• ·CRL received Jan 30, 2026 for Anaphylm NDA (human factors/PK issues, no CMC/clinical concerns)
• ·RTW agreements dated March 3, 2026: revenue sharing extension to June 30, 2027; warrant exercise price $4.00 expiring March 3, 2029; $5M share purchase in 90 days
• ·Libervant tentatively approved until Jan 2027 (orphan exclusivity expiration)
• ·AQST-108 IND opened Dec 2025; Phase 1 dosing complete Q1 2026
• ·Confidential settlement with Neurelis Dec 2025; 2026 cash impact same/lower than prior forecast
• ·Conference call March 5, 2026

04-03-2026

Atlas Lithium Corp reported total assets of $87.7M as of Dec 31, 2025, up 51.6% YoY from $57.9M, driven by cash and equivalents surging 131% to $35.9M and property/equipment rising 23.4% to $48.0M. However, accumulated deficit widened 18.8% to $171.6M from $144.4M, reflecting higher G&A expenses up $6.7M, while total liabilities remained nearly flat at $35.2M and stockholders' equity grew 138% to $52.5M amid share count increasing 68% to 27.0M shares outstanding.

• ·Current liabilities increased to $14.8M from $5.7M YoY.
• ·Trade receivables declined to $28,539 from $47,682.
• ·Capitalized exploration costs decreased $1.6M to $2.9M from $4.5M.
• ·G&A expenses increased $6.7M due to personnel and infrastructure growth.
• ·Exploration costs decreased $3.0M due to capitalization.
• ·Intangible assets acquisition decreased $0.4M.

04-03-2026

Janus International Group, Inc. (JBI) reported total revenue of $884.2M for the year ended January 3, 2026, down 8.3% YoY from $963.8M, primarily due to an 11.9% decline in product revenues to $686.9M, though service revenues grew 7.0% to $197.3M partly from $7.3M in acquisition revenue offsetting a 9.0% organic decline. Adjusted EBITDA fell 19.3% to $168.2M (19.0% margin vs. 21.6%), with self-storage segments down 9.7% overall (new construction -12.6%, R3 -4.9%), while the acquired entity showed strong growth of 41.2% to $103.9M. Net income decreased 23.6% to $53.8M amid higher operating leverage challenges.

• ·Gross profit declined 13.8% YoY to $343.0M.
• ·Operating expenses decreased 7.8% to $231.5M, driven by lower impairment charges (-94.2%).
• ·Interest expense, net improved 25.8% to $36.8M.
• ·Organic product cost of revenues declined 8.5%.
• ·Acquired entity Adjusted EBITDA surged 427.3% to $11.6M.

04-03-2026

Xperi Inc. has issued its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders on April 17, 2026, at 7:15 a.m. PT in Calabasas, CA, seeking to elect seven director nominees (Darcy Antonellis, Laura J. Durr, Jeremi T. Gorman, David C. Habiger, Jon E. Kirchner, Roderick K. Randall, and Christopher Seams) to serve until the 2027 meeting and to ratify Deloitte & Touche LLP as the independent auditor for the year ending December 31, 2026. The Board highlights strong governance practices, including a 7-member board with all directors except the CEO being independent, 100% independent key committees, and policies like stock ownership requirements (5x base salary for CEO), clawback provisions, and prohibitions on hedging/pledging. No financial performance metrics or declines are discussed.

• ·Record date: February 23, 2026
• ·Proxy materials available on or about March 4, 2026 via http://www.proxyvote.com and investor.xperi.com
• ·2025 Annual Report on Form 10-K filed with SEC on February 26, 2026
• ·All directors attended at least 75% of Board and committee meetings in 2025
• ·Minimum stock ownership: 5x base salary (CEO), 1.5x base salary (other executives), 3x annual cash retainer (independent directors)

04-03-2026

iPower Inc. (IPW) filed a DEF 14A proxy statement on March 4, 2026, for its annual meeting on April 13, 2026, seeking shareholder approval for the election of five directors: Chenlong Tan (Chairman, CEO, President, Interim CFO), Yi Yang, Bennet Tchaikovsky (Independent, Audit Chair), Hanxi Li (Independent, Compensation Chair), and Yue Guo (Independent). The board held 3 meetings and 5 written consents during the year ended June 30, 2025, with all directors attending at least 75% of meetings; three directors are independent per Nasdaq standards, while Mr. Tan holds multiple key roles with no lead independent director designated. No family relationships or legal proceedings involving directors or officers were reported.

• ·Director appointments: Yi Yang (June 6, 2025), Yue Guo (May 8, 2025), Hanxi Li (December 23, 2021), Bennet Tchaikovsky (May 2021).
• ·Chenlong Tan previously served as Interim CFO until January 2021.
• ·No involvement in bankruptcies, criminal proceedings, or securities violations by any director or officer in past 10 years.
• ·Board determines majority independent: Tchaikovsky, Li, Guo qualify under Nasdaq standards.

04-03-2026

Cardlytics, Inc. reported 2025 revenue of $233.3M, down 16% YoY from $278.3M in 2024 and continuing a decline from $309.2M in 2023, with billings falling 13% to $385.0M amid weakness in both Cardlytics platform (-13% billings) and Bridg platform (-8% billings). However, gross profit declined less sharply to $104.6M (-13% YoY), net loss narrowed significantly to $103.5M from $189.3M, Adjusted EBITDA improved to $10.1M (up 299% YoY), and operating cash flow turned positive at $9.3M versus prior cash burn. Free cash flow remained negative at $6.5M but improved from $28.1M burn.

• ·Sales and marketing expense declined to $39.5M in 2025 from $52.6M in 2024 (-25% YoY)
• ·Research and development expense fell to $39.8M from $49.6M (-20% YoY)
• ·Impairment charges of $58.8M in 2025, down from $131.6M in 2024
• ·Adjusted Net Loss per share improved to $(0.33) from $(0.39) diluted
• ·Restructuring and reduction of force costs: $3.8M in 2025
• ·Gain on divestiture: $4.8M in 2025

04-03-2026

Xanadu Quantum Technologies Inc. hosted its 2026 Analyst Day on March 4, 2026, outlining its strategic roadmap and business combination with Crane Harbor Acquisition Corp., implying a $3.1B pro forma enterprise value, $500M gross proceeds including a $275M PIPE, and $455M expected net cash at closing assuming no redemptions. The event highlighted Xanadu's photonic quantum computing leadership with products like Aurora and PennyLane, targeting commercialization by 2029+, while noting well-capitalized position post-merger. However, risks include historical net losses, substantial doubt about going concern, potential redemptions reducing cash, and technical challenges in quantum computing commercialization.

• ·Shareholder meetings scheduled for March 19, 2026
• ·Transaction expected to close in Q1 2026
• ·Registration Statement on Form F-4 declared effective by SEC on February 27, 2026
• ·Crane Harbor trust account value as of September 30, 2025
• ·NewCo expected to trade on Nasdaq and Toronto Stock Exchange under ticker XNDU

04-03-2026

Diversified Energy Company (NYSE: DEC, LSE: DEC) announced the execution of a purchase and sale agreement to acquire high-working interest natural gas properties and facilities in east Texas from Sheridan Production for $245M in cash, expected to close in Q2 2026 and funded via existing liquidity. The acquisition adds ~62 MMcfepd (~10 MBoepd) of 2026 production with low ~6% annual declines, ~$52M NTM EBITDA, and ~397 Bcfe PDP reserves at $310M PV-10, at an accretive ~PV-15 net valuation. The assets are contiguous to existing operations, offering synergies, with no declines in consolidated production profile pro forma.

• ·Assets based on NYMEX strip as of February 2, 2026, with terminal prices of $3.75/MMBtu gas and $65/Bbl oil
• ·Expected to maintain unchanged consolidated decline rate pro forma
• ·Includes opportunities for future operating efficiencies and upside from undeveloped acreage

04-03-2026

Miller Industries Inc. (MLR) reported net sales of $790.3M for the year ended December 31, 2025, down 37.2% YoY from $1.26B in 2024, with gross profit declining 29.5% to $120.4M and net income falling 63.8% to $23.0M from $63.5M. While selling, general, and administrative expenses rose modestly 3.1% to $89.0M, operating cash flow improved dramatically 485.2% to $98.7M, driving a net increase in cash to $44.7M, and long-term obligations decreased to $31.1M from $65.0M. Total assets stood at $589.7M with shareholders' equity up to $420.6M despite the revenue drop.

• ·Diluted EPS $1.98 in 2025 vs $5.47 in 2024 (down 63.8%)
• ·Cash dividends declared per share $0.80 in 2025 (up from $0.76 in 2024)
• ·Inventories net flat at $184.2M vs $186.2M YoY
• ·Allowance for credit losses $1.876M (0.9% of receivables) vs $1.850M (0.6%) YoY
• ·Weighted-average diluted shares 11,615 thousand in 2025 (up slightly from 11,602 thousand)

04-03-2026

MOZAYYX Acquisition Corp., a blank check company, consummated its upsized initial public offering on February 26, 2026, of 30,000,000 units at $10.00 per unit, generating $300M in gross proceeds, including 3,900,000 units from partial over-allotment exercise. Simultaneously, it completed a private placement of 3,610,000 warrants for $7.22M to its sponsor and Cantor Fitzgerald & Co. The balance sheet as of February 26 reflects $301.64M total assets with $300M in trust, but shows a $11.38M shareholders' deficit and $13.02M liabilities primarily from deferred underwriting fees of $12.78M.

• ·Of private placement warrants: 2,305,000 to sponsor and 1,305,000 to Cantor Fitzgerald & Co.
• ·Prepaid expenses: $10,500; Related party payable: $142,934; Accrued expenses: $98,115.
• ·Class B ordinary shares include up to 375,000 subject to forfeiture related to over-allotment.

04-03-2026

M/I Homes, Inc. announced that independent Director Norman L. Traeger has decided to retire from the Board upon the expiration of his term, having served since 1997. Chairman and CEO Robert H. Schottenstein commended Traeger's guidance, wisdom, and contributions to the company's success and growth. The announcement is neutral with no financial impacts disclosed.

• ·Company homebuilding operations in: Columbus and Cincinnati, Ohio; Indianapolis, Indiana; Chicago, Illinois; Minneapolis/St. Paul, Minnesota; Detroit, Michigan; Tampa, Sarasota, Fort Myers/Naples and Orlando, Florida; Austin, Dallas/Fort Worth, Houston and San Antonio, Texas; Charlotte and Raleigh, North Carolina; Nashville, Tennessee.

04-03-2026

Viper Energy, Inc. announced the pricing of a secondary public offering of 17,391,304 shares of Class A common stock by Diamondback Energy, Inc. and affiliates of EnCap Investments, L.P. and Oaktree Capital Management, L.P., generating approximately $798M in gross proceeds solely for the selling stockholders, with Viper receiving no proceeds. Concurrently, Viper agreed to purchase 1,000,000 units in VNOM Holding Company LLC from Oaktree affiliates at the offering price per share equivalent. The offering is expected to close on March 4, 2026, subject to customary conditions, with underwriters granted a 30-day option for up to 2,608,696 additional shares.

• ·Selling Stockholders granted underwriters a 30-day option to purchase up to 2,608,696 additional shares solely for over-allotments.
• ·Concurrent OpCo Unit Purchase is conditioned on Secondary Offering completion, but not vice versa.
• ·J.P. Morgan and Goldman Sachs & Co. LLC acting as joint book-running managers.

04-03-2026

Albemarle Corporation (NYSE: ALB) appointed Michelle T. Collins and Mark R. Widmar to its Board of Directors, effective February 26, 2026, as part of regular succession planning to enhance governance and long-term value creation. Collins, a former Vice Chair and Senior Audit Partner at Deloitte & Touche LLP with over 40 years of experience, will join the Audit & Finance Committee and Governance & Public Policy Committee. Widmar, CEO of First Solar since 2016, will join the Executive Compensation & Talent Development Committee and Safety, Sustainability, Operations & Capital Committee.

• ·Press release dated March 2, 2026; SEC filing dated March 4, 2026
• ·Collins served on Deloitte U.S. Board for six years as Vice Chair, Chair of Finance and Audit Committee, and Chair of Governance Committee
• ·Widmar previously CFO at First Solar, GrafTech (2006-2011), and held financial roles at NCR Inc. and Dell Inc.; career started at Ernst & Young in 1987

04-03-2026

Michael D. Lynch, Executive Vice President and Chief Financial Officer of AmeriServ Financial, Inc., announced his retirement after a long career of over 40 years, effective May 18, 2026. The company is conducting a search for his replacement. The filing was reported on March 4, 2026, and signed by Jeffrey A. Stopko, President and Chief Executive Officer.

• ·Company headquartered at Main and Franklin Streets, Johnstown, PA 15901
• ·Telephone: 814-533-5300
• ·Common Stock traded as ASRV on NASDAQ

04-03-2026

Westwood Holdings Group, Inc. reported 2025 total revenues of $97.8M, up 3% YoY from $94.7M, with net income attributable to the company surging 219% to $7.1M from $2.2M amid lower expenses and higher net operating income. However, total AUM dipped 0.4% to $16.5B from $16.6B, reflecting worsened net client outflows of $1.0B versus $0.8B in 2024, with declines in Wealth Management (-1.7%) and Mutual Funds & ETFs (-0.6%) AUM partially offset by flat Institutional AUM. Economic Earnings doubled 105% to $14.3M, while Advisory net income rose 13% to $19.9M.

• ·Asset-based advisory fees grew 7% YoY to $74.7M in 2025, while performance-based fees declined 37% to $0.9M.
• ·Total expenses decreased 1% YoY to $92.8M in 2025.
• ·AUA end 2025 at $942M, down from $960M end 2024.
• ·2024 quarterly revenues: Q1 $17.2M, Q2 $15.6M, Q3 $15.4M, Q4 $20.5M.

04-03-2026

Lithia Motors, Inc. entered into the Seventh Amendment to its Fourth Amended and Restated Loan Agreement on February 27, 2026, extending the credit facility's expiration date to February 27, 2031, with annual 1-year extension options subject to lender consent and conditions. The amendment introduces VIN-specific reporting for Used Vehicle and Service Loaner Floorplan facilities (upon company election) and reallocates commitments to $2.7B for New Vehicle Floorplan, $1.25B for Used Vehicle Floorplan, $150M for Service Loaner Floorplan, and $2.4B for Revolving Line of Credit. It also removes the Simple SOFR Adjustment.

• ·Original Loan Agreement dated April 29, 2021
• ·Filing submitted on March 4, 2026

04-03-2026

TriplePoint Venture Growth BDC Corp. (TPVG) reported portfolio fair value growth of 16% YoY to $784M at December 31, 2025, supported by $283M in new debt investments, increasing total debt investments 15% to $645M primarily in growth capital loans (95.6%). However, net investment income declined 23% YoY to $42M with weighted average yield dropping to 13.7% from 15.7%, NAV per share slipped slightly to $8.73 in Q4 2025 amid a downward trend from $9.02 in Q1 2024, and shares traded at widening discounts to NAV reaching -40% at 2025 lows. Portfolio companies expanded to 55 from 44, but included higher-risk Orange (3.9%) and Red (0.6%) credits.

• ·Principal prepayments and early repayments totaled $135M in 2025 vs $179M in 2024.
• ·Credit breakdown at Dec 31, 2025: White 75.1% ($485M, 43 cos), Yellow 13.4% ($86M, 4 cos), Orange 3.9% ($25M, 4 cos), Red 0.6% ($4M, 1 co).
• ·Interest rate sensitivity: Net investment income increases $7M if rates up 300bps, resilient with $1.7M gain even if down 300bps.
• ·Distributions: Q4 2025 $0.25/share, down from $0.30/share in Q4 2024; Q1 2026 partial $0.23/share.

04-03-2026

Third Coast Bancshares, Inc. reported net income of $66.3M for the year ended December 31, 2025, up 39.1% YoY from $47.7M in 2024, fueled by net interest income growth of 21.4% to $195.2M and noninterest income increase of 28.5% to $13.7M, with net interest margin expanding to 4.06%. However, provision for credit losses rose 33.1% to $7.6M, signaling potential credit pressures, while noninterest expenses increased 13.6% to $118.5M. Compared to 2023, 2024 net income grew 42.7% to $47.7M.

• ·Average yield on gross loans declined slightly to 7.68% in 2025 from 7.80% in 2024.
• ·(Loss) gain on sale of investment securities available-for-sale worsened to ($0.6M) in 2025 from ($0.0M).
• ·Service charges and fees surged 55.1% YoY to $10.8M in 2025.
• ·Salaries and employee benefits, the largest noninterest expense, rose 18.5% to $77.2M.

04-03-2026

Johnson Outdoors Inc. announced on March 4, 2026, that David W. Johnson, its Vice President and Chief Financial Officer since November 2005, intends to retire later this year. The company has commenced a succession process to identify a successor, with Mr. Johnson expected to assist in the transition. His decision to retire is not due to any disagreement with the company's financial statements, reporting matters, or policies.

• ·Mr. Johnson has served as VP and CFO (principal financial and accounting officer) since November 2005.
• ·Company principal executive offices: 555 Main Street, Racine, Wisconsin 53403.

04-03-2026

Genesis Energy, L.P. and Genesis Energy Finance Corporation closed a $750 million offering of 6.750% senior notes due May 15, 2034, on March 4, 2026, following the Underwriting Agreement dated February 18, 2026. Net proceeds will fund the redemption of all outstanding 7.75% senior notes due 2028 and general partnership purposes, including partial repayment of revolving borrowings under the senior secured credit facility. The new notes are senior unsecured obligations ranking equal with existing senior debt totaling $2.4 billion across maturities from 2029 to 2033.

• ·Interest on new notes accrues at 6.750% per year, payable semi-annually on March 15 and September 15, commencing September 15, 2026.
• ·Indenture governed by Base Indenture dated May 21, 2015, supplemented by Twenty-Fourth Supplemental Indenture dated March 4, 2026.

04-03-2026

Global Water Resources, Inc. reported FY2025 revenue growth of 5.8% YoY to $55.8M from $52.7M, driven by water service revenue up 9.8% and total active connections increasing 6.3% to 68,577. However, operating expenses rose 12.2% to $48.6M, resulting in operating income declining 23.6% to $7.2M and net income dropping sharply 48.9% to $3.0M with EPS at $0.11 (down from $0.24). Total assets expanded to $483M from $405M, supported by utility plant growth.

• ·Approved ROE ranges 9.20%-9.60% across utilities; recent GW-Farmers rate case approved $1.1 incremental annual revenue effective May 1, 2025.
• ·Pending rate cases for GW-Santa Cruz and GW-Palo Verde filed March 5, 2025.
• ·Shareholders' equity increased to $86.6M from $47.6M; long-term debt $129.8M.
• ·Dividends declared per common share remained flat at $0.30.

04-03-2026

Silver North Resources Ltd. reported a sharply reduced net loss of $406k for the fiscal year ended 9/30/25 compared to $2.03M in FY24, aided by lower expenses including investor relations and a $449k flow-through share premium recovery, while total assets grew 38% to $10.8M and shareholder equity rose 42% to $9.4M on $3.8M in private placement proceeds. Cash balances strengthened to $1.8M from $0.7M, and working capital turned positive at $934k from a $361k deficit. However, revenue remained at $0, the company recorded ongoing operating cash burn of $1.1M, and share count diluted 57% to 74.9M outstanding amid continued exploration spending.

• ·Operating cash use improved slightly to $1.1M from $1.3M YoY but remains negative.
• ·Investor relations expenses declined to $451k from $603k YoY, while wages/consulting fell to $140k from $179k.
• ·USD stock average price stable at $1.40 for year ended 12/31/25 vs $1.37 prior year.
• ·No long-term debt in any period.

04-03-2026

Air T, Inc. entered into a new employment agreement with Tracy Kennedy, its Chief Financial Officer, effective February 27, 2026, providing a base salary of $331,000 per year, increasing to $360,000 effective January 1, 2027, and $397,000 effective January 1, 2028. The agreement includes eligibility for quarterly incentive compensation based on performance ratings (0% to 90%+ of quarterly base salary) and severance of up to 12 months of base salary upon termination without cause. No performance declines or flat metrics are mentioned in the filing.

• ·Employment is at-will with standard benefits, four weeks vacation, and restrictive covenants (non-competition, non-solicitation, non-disparagement, confidentiality).
• ·Quarterly incentives may be paused in cases of significant financial distress impacting debt obligations.
• ·Severance contingent on execution of general release of claims.

04-03-2026

Mayville Engineering Company, Inc. (MEC) reported net sales of $546.5M for the year ended December 31, 2025, down 6% YoY from $581.6M in 2024, amid macroeconomic pressures including inflation and material costs. Net income swung to a $8.1M loss from $26.0M profit in 2024, with EBITDA dropping 54% to $37.4M (6.9% margin) and Adjusted EBITDA declining 27% to $47.1M (8.6% margin); however, free cash flow remained positive at $26.9M despite a 65% YoY drop from $77.7M.

• ·Capital expenditures: $11.6M in 2025 vs $12.1M in 2024.
• ·Interest expense: $10.2M in 2025, slightly down from $11.0M in 2024.
• ·Acquisition related costs: $3.4M in 2025.
• ·Natural disaster costs: $0.3M in 2025.

04-03-2026

Nine Energy Service, Inc. reported revenues of $561.9M for the year ended December 31, 2025, up 1% YoY from $554.1M, driven by a 2% increase in service revenues to $431.2M, while product revenues declined slightly to $130.7M. However, the company posted a larger net loss of $51.3M (25% worse YoY) versus $41.1M in 2024, with operating income dropping 74% to $2.3M and Adjusted EBITDA falling to $49.4M from $53.2M. Cash and cash equivalents decreased to $18.4M from $27.9M, total debt rose to $369.6M, and stockholders' deficit widened to $(115.0M) from $(66.1M).

• ·Gross profit slightly declined to $60.6M from $61.1M YoY.
• ·Net cash used in operating activities was $7.3M in 2025 versus $13.2M provided in 2024.
• ·Total assets decreased to $339.5M from $360.1M.
• ·ROIC worsened to -20.8% from -14.9%, while Adjusted ROIC improved to 4.4% from 3.7%.
• ·Loss per share (basic and diluted) was $(1.25) versus $(1.11) YoY.

04-03-2026

DynaResource, Inc. approved the engagement of David Keough, an experienced mining executive, through his consulting firm Vulcan’s Forge Capital Pty. Ltd. to perform the functions of Chief Operating Officer, effective June 23, 2025. Compensation includes a $20,000 monthly consulting fee, 450,000 restricted stock units vesting in three equal annual installments starting August 12, 2025, and eligibility for an annual discretionary cash bonus up to 50% of prior year fees. The consulting agreement, dated February 26, 2026 but effective August 15, 2025, includes severance provisions for termination without cause.

• ·RSUs vest in three equal annual installments on the first three anniversaries of August 12, 2025 grant date.
• ·Termination without cause entitles Consultant to nine months of fees ($180,000) plus prorated bonus.
• ·Post-change in control termination without cause or for good reason entitles to 18 months of fees plus 18 months prorated bonus.

04-03-2026

Actelis Networks, Inc. is convening a special stockholder meeting on April 13, 2026, at 10:00 a.m. EST in Petach Tikva, Israel, to vote on three proposals: (1) authorizing issuance of common stock under the ELOC Purchase Agreement per Nasdaq Listing Rule 5635(d), (2) approving a reverse stock split amendment at a 1-for-10 to 1-for-25 ratio to be determined by the Board, and (3) approving adjournment if needed for additional solicitation. The record date is February 13, 2026, with 8,759,402 shares outstanding requiring a quorum of 2,919,801 shares (one-third). The Board recommends voting FOR all proposals, with proxies solicited by CEO Tuvia Barlev and CFO Yoav Efron.

• ·Common stock par value: $0.0001 per share
• ·Proxy materials mailed on or about March 4, 2026
• ·Meeting location: 25 Bazel Street, Petach Tikva, Israel 4950138
• ·Transfer agent: Vstock Transfer, LLC

04-03-2026

On November 11, 2025, Blueport Acquisition Ltd entered into a consulting agreement with Hurricane Corporate Services Ltd., controlled by CFO Kulwant Sandher, for CFO services at $3,000 per month plus expenses, initially for three months with automatic renewal on February 11, 2026. Separately, in November 2025, the Company orally agreed to pay each director $7,500 per quarter for board services, terminable at any time. No departures, elections, or performance metrics were reported.

• ·Consulting Agreement includes mutual indemnification for breaches or negligent acts.
• ·Agreement filed as Exhibit 10.1.
• ·Company is an emerging growth company.

04-03-2026

European Wax Center, Inc. reported total revenue of $206.6M for FY2026 ended January 3, 2026, down 4.7% YoY from $216.9M, driven by declines in product sales (-7.3%) and flat same-store sales growth of 0.2%, amid net center closures of 20 (total centers 1,047 vs 1,067). Net income fell 19.2% to $11.9M, with income attributable to EWCZ down 17.0% to $8.7M, though Adjusted EBITDA remained relatively stable at $73.3M (down 2.9%) and operating income margin contracted to 20.7% from 22.0%. Cash and equivalents strengthened to $76.1M from $49.7M, boosting total assets to $725.3M.

• ·Cash flow from operating activities: $53.0M FY2026 vs $56.5M FY2025 (down 6.2%)
• ·Long-term debt stable at ~$375M
• ·Treasury stock increased to 9.8M shares from 8.4M shares
• ·Weighted average basic shares Class A: 43.4M FY2026 vs 46.8M FY2025

04-03-2026

Stellar V Capital Corp., a blank check company, elected Michael Braunstein as a class II director on February 28, 2026, to fill the vacancy left by his father Harry Braunstein, who passed away on November 2, 2025. Michael Braunstein, deemed independent under NASDAQ rules, will serve on the Audit Committee and Compensation Committee and chair the Nominating and Corporate Governance Committee. The appointment was recommended by the Nominating and Governance Committee.

• ·Michael Braunstein has been a partner of Braunstein Turkish LLP since September 2009 and managing member of Sunset Capital 1 LLC and affiliates since November 2025.
• ·From January 2024 to November 2025, Michael Braunstein was president of Sunset Capital 1 LLC and affiliates; from January 2019 to December 2023, vice president.
• ·Michael Braunstein holds a bachelor’s degree in music business from New York University (2004) and Juris Doctor from Brooklyn Law School (2009).

04-03-2026

Designer Brands Inc. and its subsidiaries entered into a Third Amendment to their Credit Agreement on February 27, 2026, with The Huntington National Bank as Administrative Agent, primarily to extend the Maturity Date and amend certain provisions of the existing agreement originally dated March 30, 2022. The amendment's effectiveness is conditioned on, among other things, a Borrowing Base Certificate demonstrating Availability of no less than $90,000,000 as of January 31, 2026, confirmation of no Defaults or Events of Default, and no Material Adverse Effect since November 30, 2025. All Loan Documents are ratified and reaffirmed.

• ·Previous amendments: First Amendment on February 28, 2023; Joinder and Second Amendment on June 23, 2023.
• ·Conditions include recent lien searches revealing no impermissible Liens, favorable legal opinions from Vorys, Sater, Seymour and Pease LLP and Osler, Hoskin & Harcourt LLP, and payment of fees per Third Amendment Fee Letter.
• ·Governing law: State of New York.

04-03-2026

Walker & Dunlop, Inc. and Walker & Dunlop, LLC entered into the Seventeenth Amendment to their Second Amended and Restated Warehousing Credit and Security Agreement with PNC Bank, effective March 2, 2026, extending the Warehousing Maturity Date to March 1, 2027. The amendment permits incremental increases to the Standard Warehousing Credit Limit in $100M minimum increments (each for 45 days) up to the Maximum Warehousing Credit Limit and a one-time Limited Bulge Increase up to $2.5B USD through May 1, 2026, subject to Lender discretion. Associated fees include an annual 10 basis points on the Standard Limit, $10,000 per $100M incremental increase, and a daily 7.5 basis points bulge commitment fee.

• ·Incremental increases to Standard Warehousing Credit Limit effective for 45 days each
• ·Limited Bulge Increase available from March 2, 2026 to May 1, 2026
• ·Original Credit Facility Agreement dated September 11, 2017, with 16 prior amendments listed

04-03-2026

Franklin Street Properties Corp. (FSP) closed a $320M secured credit facility with an affiliate of TPG Credit, using an initial $258.5M drawdown (net of $16.5M original issue discount) to fully repay $248.9M of outstanding indebtedness, with up to $45M available in delayed draw term loans for tenant improvements and other uses. The facility features a 9.0% initial coupon rate, 4.0% exit fee, and maturity on February 26, 2029, secured by a first priority lien on substantially all assets. Management highlighted the refinancing as addressing near-term debt maturities amid an uneven office market, while continuing review of strategic alternatives to maximize shareholder value.

• ·Facility maturity date: February 26, 2029, with potential one-year extension at company's option subject to conditions.
• ·Collateral: first priority lien on substantially all assets of the Company.
• ·Core markets: Dallas, Denver, Houston, and Minneapolis.

04-03-2026

Octave Specialty Group Inc reported total revenues of $251.2M for FY 2025, up 6.5% YoY from $235.8M, driven by strong Insurance Distribution segment growth with premiums placed nearly doubling to $951.8M (+93%) and commissions rising 56% to $143.4M. However, the company posted a widened net loss from continuing operations of $(95.8M) vs $(58.9M) in 2024, with Specialty Property & Casualty Insurance seeing gross premiums written decline 5.8% to $360.4M, net premiums written drop 17% to $73.9M, and combined ratio worsen to 105.2%. Operating cash flow turned negative at $(52.3M) from positive $0.8M.

• ·Adjusted EBITDA attributable to shareholders FY2025: $(7.5M) vs $2.2M FY2024
• ·Specialty P&C retention ratio declined to 20.5% from 23.2% YoY
• ·Insurance Distribution pretax loss $(20.5M) vs $(7.8M) YoY, despite revenue growth
• ·Corporate & Other pretax loss $(83.9M) vs $(64.3M) YoY
• ·Net cash flow FY2025: $21.4M vs $28.6M FY2024

04-03-2026

On February 26, 2026, the Compensation Committee of Quanta Services, Inc.'s Board of Directors adopted the 2026 Incentive Plan, encompassing the annual incentive plan for corporate employees, long-term incentive plan for senior leadership, and discretionary plan for all employees. Executive officers and certain employees are eligible for cash, restricted stock units (RSUs), and/or performance stock units (PSUs) based on metrics such as EBITDA, EBITDA margin, and safety for annual awards, and return on invested capital (ROIC), earnings per share (EPS), and total stockholder return (TSR) for the January 1, 2026 to December 31, 2028 performance period. All equity awards will be issued under the Quanta Services, Inc. 2019 Omnibus Equity Incentive Plan, as amended.

• ·Awards governed by Exhibits 10.1 through 10.6, including term sheets and forms of PSU and RSU award agreements.
• ·Performance period for long-term incentives: January 1, 2026 through December 31, 2028.

04-03-2026

Red Violet, Inc. reported FY2025 revenue of $90.3M, up 20% YoY from $75.2M, with net income surging 88% to $13.2M, Adjusted EBITDA increasing 31% to $31.0M, and Adjusted EBITDA margin expanding to 34% from 31%. Q4 2025 revenue grew 20% YoY to $23.4M and net income rose 226% to $2.8M, but operating cash flow remained flat YoY at $6.7M while free cash flow declined 17% to $3.7M, and income from operations fell QoQ from $4.6M in Q3 to $1.6M.

• ·Total assets grew to $112.0M from $98.5M as of Dec 31, 2025.
• ·Cash and equivalents increased to $43.6M from $36.5M.
• ·Gross margin stable at 72% for FY2025 and Q4.
• ·Adjusted gross margin improved to 84% FY2025 from 81%.
• ·Accounts receivable net $10.7M (Dec 2025) vs $8.1M (Dec 2024).
• ·Intangible assets net $39.3M (Dec 2025) vs $36.0M (Dec 2024).

04-03-2026

OmniAb, Inc. reported total revenue of $18.7M for the year ended December 31, 2025, down 29% YoY from $26.4M, primarily due to sharp declines in license and milestone revenue (-30%) and service revenue (-39%), while xPloration revenue was newly introduced at $0.8M (+100%) and royalty revenue grew 52%. Total costs and operating expenses fell 13% to $87.6M, improving loss before taxes by 7%, but net loss widened 4% to $64.8M amid a reduced tax benefit. Cash used in operating activities improved to $36.5M from $39.7M, supported by $27.9M in financing inflows.

• ·Diluted EPS improved to $(0.57) from $(0.61) YoY.
• ·Total assets declined to $300.9M from $325.6M as of Dec 31.
• ·Accumulated deficit grew to $166.2M from $101.4M.
• ·Stockholders' equity decreased to $267.0M from $287.6M.

04-03-2026

Unity Bancorp, Inc. reported strong FY2025 results with net income per diluted share up 39.7% to $5.67 from $4.06 in FY2024, driven by net interest income increasing 18.7% to $117.0 million and noninterest income surging 74.5% to $14.8 million. However, noninterest expenses rose $3.7 million to $52.4 million due to higher compensation, processing, and occupancy costs. Net income before provision for income taxes grew 38.8% to $75.5 million, with GAAP net income at $58.0 million versus $41.5 million prior year.

• ·Return on average assets improved to 2.17% from 1.68%.
• ·Return on average equity rose to 18.07% from 14.99%.
• ·Dividend payout ratio decreased to 10.23% from 12.81%.
• ·Adjusted net income (non-GAAP) increased to $51.8M from $41.5M after adjustments for securities gains and credit loss releases.

04-03-2026

NACCO Industries reported FY2025 total revenue of $277.2M, up 16.6% YoY from $237.7M, with Utility Coal Mining surging 28.5% to $88.2M and Contract Mining growing 17.1% to $140.0M, while Minerals and Royalties increased 8.9% to $37.6M. However, operating profit fell 38.4% to $22.0M from $35.7M, primarily due to higher unallocated items losses and a $7.8M pension settlement charge, resulting in net income declining 47.9% to $17.6M from $33.7M. Cash from operating activities improved sharply to $50.9M from $22.3M, though cash and equivalents decreased to $49.7M.

• ·Expenditures for PP&E and mineral interests: $53.3M in 2025 (down $2.1M YoY)
• ·Pension settlement charge: $7.8M in 2025
• ·Closed mine obligations: $24.7M at Dec 31, 2025 (down from $25.8M)
• ·Gain on settlement of excess funding liability: $3.6M in 2025

04-03-2026

Impact BioMedical Inc. amended its Merger and Share Exchange Agreement dated June 21, 2025, extending the termination date from March 31, 2026, to July 1, 2026, and providing for issuance of 53,000 PubCo ordinary shares (first batch) and 75,000 (second batch) to DSS, Inc., plus 22,000 to CEO Frank D. Heuszel, all deducted from the 169,560,000 shares (94.20% ownership) to be issued to the Dr Ashleys Shareholder at closing. Amendments to the Voting and Support Agreement updated supporting stockholders' ownership to 92,980,843 Impact shares (88.87% on fully diluted basis), and the Transition Arrangement Agreement outlined DSS funding obligations tied to the share issuances. No financial metrics or performance declines were reported.

• ·Merger termination End Date extended to July 1, 2026 (previously March 31, 2026).
• ·Impact required to seek board approval for certain loan agreements prior to Effective Time.
• ·DSS shares issuance subject to effectiveness of registration statement and full performance of funding obligations.

04-03-2026

Orthopediatrics Corp (KIDS) reported net revenue of $236.3M for FY 2025, up 15% YoY from $204.7M, with U.S. revenue at $186.4M (79% of total, +16% YoY) and international at $50.0M (21%, +15% YoY); product categories showed Trauma & Deformity up 15% to $166.3M (70%), Scoliosis up 20% to $66.0M (28%), but Sports medicine/other down 10% to $4.0M (2%). However, net loss widened 5% YoY to $39.6M amid higher sales & marketing (+13%), G&A (+17%), impairment (+153%), and restructuring (+53%) expenses, despite R&D down 18%; operating loss increased to $39.2M. Cash and restricted cash decreased $24.2M to $21.6M, with total assets at $508.6M but stockholders' equity down to $346.6M.

• ·Gross profit $172.7M FY2025 (+16% YoY from $148.6M).
• ·Operating expenses totaled $211.9M (+15% YoY).
• ·Long-term debt increased to $48.2M term loan and $48.5M convertible note.
• ·Accumulated deficit grew to $275.2M.
• ·Shares outstanding increased to 25.1M from 24.2M.

04-03-2026

Viemed Healthcare, Inc. reported FY2025 revenue of $270.3M, up 20.5% YoY from $224.3M, with strong growth in equipment sales (+62.7% to $50.3M) and PAP therapy patients (Q4: 34,528 vs. 21,338 prior year). Net income attributable to the company increased 32.6% to $14.9M, and adjusted EBITDA reached $61.4M across quarters. However, gross margin declined to 57.5% from 59.4%, SG&A rose 14.3% to $121.4M, and net cash decreased $4.0M due to higher investing outflows of $50.2M.

• ·Vent patients Q4 2025: 12,259 (up from 11,795 Q4 2024, +3.9%)
• ·Investing cash outflows FY2025: $50.2M (vs. $30.7M FY2024)
• ·R&D expenses FY2025: $3.0M (down 1.7% YoY)

04-03-2026

AIAI Holdings Corp filed an S-1/A amendment on March 4, 2026, for a direct listing as an emerging growth company with no operating history, formed on July 19, 2024, and no established financial sources or AI application to Portfolio Companies yet. The filing extensively details risk factors such as dependence on acquiring additional Portfolio Companies, potential integration failures, limited public company experience of management, high key personnel turnover risk, and acquisition-related costs that could dilute shareholders or lead to losses. No financial metrics or performance data are provided, underscoring substantial uncertainties and high investment risks.

• ·Company qualifies as emerging growth company (EGC) with elected extended transition period for new accounting standards.
• ·No 'key person' insurance on employees.
• ·Substantially all Portfolio Company key personnel have at-will employment.

04-03-2026

Riley Exploration Permian, Inc. (REPX) reported net oil and natural gas sales of $392M for the year ended December 31, 2025, down 4% YoY from $410M in 2024, driven by lower realized oil prices ($62.95/Bbl vs. $74.10) despite a 29% increase in total production to 10,660 MBoe (daily volumes up to 29,205 Boe/d from 22,546). Oil production rose 15% to 6,328 MBbls, but natural gas and NGL sales posted net losses of $3.3M and $3.0M respectively due to elevated GP&T costs ($57.8M total). Average operating costs per Boe improved slightly, with LOE at $8.21 vs. $8.66 YoY.

• ·Natural gas sales net loss widened to $(3.3M) in 2025 from $(1.4M) in 2024 due to higher GP&T costs.
• ·NGL sales turned to net loss of $(3.0M) in 2025 from $2.3M profit in 2024.
• ·Production and ad valorem taxes per Boe declined to $2.73 in 2025 from $3.57 in 2024.

04-03-2026

Middleby Corp reported FY2025 net sales of $3.2B, up 1.6% YoY from $3.2B, with Food Processing segment growing 10.4% to $850.2M while Commercial Foodservice declined 1.2% to $2.4B. Net earnings from continuing operations decreased 12.8% to $367.3M (11.5% margin vs 13.4%), but overall net loss was $277.7M due to $645.0M discontinued operations loss from $704.4M impairments in Residential Kitchen Equipment Group. Stockholders' equity fell to $2.8B from $3.6B, impacted by $729.7M treasury stock repurchases.

• ·Cash and cash equivalents declined to $222.2M from $638.8M YoY.
• ·Long-term debt decreased to $2.1B from $2.4B.
• ·Goodwill balance $1.8B as of Jan 3, 2026.
• ·Impairment test performed as of Sep 27, 2025 for Residential Kitchen Equipment Group.
• ·Current assets held for sale - discontinued operations: $1.1B as of Jan 3, 2026.

04-03-2026

On February 26, 2026, Glen W. Herrick resigned immediately as director of MVB Financial Corp and MVB Bank, Inc., where he served as Chair of the Audit Committee and a member of the Finance Committee, citing concerns with the Company's corporate governance practices, executive compensation philosophy, and strategic focus. Cheryl Spielman, an existing Audit Committee member and qualified audit committee financial expert, was appointed as the new Chair of the Audit Committee. The resignation letter does not implicate any issues with financial statements, accounting, internal controls, or auditing.

• ·Resignation letter attached as Exhibit 17.1.
• ·Company provided disclosures to Mr. Herrick and will file any response letter from him as an amendment within two business days of receipt.
• ·Filing signed by Michael R. Sumbs on March 4, 2026.

04-03-2026

WesBanco, Inc.'s Board reduced its size from 19 to 15 directors effective after the April 2026 Annual Meeting, accepting voluntary retirements from Abigail M. Feinknopf, James W. Cornelsen, D. Bruce Knox, and Michael J. Crawford (the latter due to age policy), with no disagreements on company matters. Retiring directors received a one-time equity grant of restricted common stock valued at $250,000. To balance board classes, John L. Bookmyer and Joseph R. Robinson were reclassified and nominated for election at the 2026 Annual Meeting.

• ·Retirements and board size reduction effective at conclusion of 2026 Annual Meeting in April 2026.
• ·Bookmyer nominated for three-year term expiring 2029; Robinson for one-year term expiring 2027.
• ·Reclassifications of Bookmyer and Robinson solely for class balance; service deemed uninterrupted for committees and compensation.

04-03-2026

Proved reserves grew 14% YoY to 153.3M Boe as of December 31, 2025, driven by purchases of minerals in place (+14M Boe) and extensions/discoveries (+11.2M Boe), with oil up 12%, gas up 18%, and NGL up 19%. However, the standardized measure of discounted future net cash flows declined 9% YoY to $1.12B due to lower prices, including oil sales down 15% to $63.53/Bbl and total per Boe down 18% to $41.55/Boe, while gas prices remained negative at -$1.33/Mcf. Pre-tax PV-10 value stood at $1.32B, with top three customers (Phillips 66, Concord Energy, NGL Crude) comprising 89% of revenues.

• ·Phillips 66 represents 67% of revenues and 66% of accounts receivable.
• ·Texas reserves account for nearly 100% of total proved reserves (152.98M Boe).
• ·No purchases or sales of minerals in place from New Mexico.
• ·Future production costs as of Dec 31, 2025: $2.47B.
• ·Revisions to previous quantity estimates added 1.34M Boe net in 2025.

04-03-2026

IREN Limited entered into purchase agreements for over 50,000 NVIDIA B300 GPUs, expanding its total AI cloud fleet to 150,000 GPUs with phased deployments through H2 2026 across data centers in Mackenzie, British Columbia, and Childress, Texas. This expansion is projected to support over $3.7B in annualized AI Cloud run-rate revenue by end-2026, backed by $9.3B in secured funding over the past eight months and planned $3.5B additional capex in H2 2026. Figures are illustrative, not fully contracted, and subject to execution risks including timely delivery and contracting.

• ·Deployment phases through H2 2026 in air-cooled data centers at Mackenzie, British Columbia and Childress, Texas; existing capacity at Canal Flats.
• ·Payment terms structured post-shipment for working capital efficiency; procurement sequenced with commercial milestones and capital availability.

04-03-2026

On February 26, 2026, Chui Tin Mok, an executive director on the Board of Faraday Future Intelligent Electric Inc., notified the Board of his intent to resign upon confirmation of a successor to focus on business execution in the UAE and Middle East. He will continue serving as an executive officer and Head of FF Middle East. The resignation has no immediate impact as no successor is yet named.

• ·Trading symbols: FFAI (Class A common stock), FFAIW (redeemable warrants) on Nasdaq Stock Market LLC
• ·Company confirmed as emerging growth company
• ·Business address: 18455 S. Figueroa Street, Gardena, CA 90248
• ·Former name: Property Solutions Acquisition Corp. (changed March 4, 2020)

04-03-2026

XWELL, Inc. designated 35,000 shares of Series H Convertible Preferred Stock with a stated value of $1,000 per share (total $35M) and an initial conversion price of $0.47 into common stock, adopted by the Board on February 26, 2026, pursuant to a Securities Purchase Agreement dated February 24, 2026. The preferred stock is immediately convertible at the holder's option, subject to a 4.99% beneficial ownership limitation (increaseable to 9.99%). No financial performance metrics or period comparisons are provided in the filing.

• ·Certificate of Designation filed as EX-3.1 with 8-K on March 04, 2026
• ·Conversion shares issuable: Stated Value divided by Conversion Price
• ·Delivery of conversion shares required within 5 business days
• ·Adjustments to Conversion Price for stock splits, combinations, or reclassifications
• ·No dividends on Series H Preferred Stock unless consented by Required Holders and paid pro rata as-if-converted

04-03-2026

InspireMD, Inc. provided notice of dismissal to Chief Operating Officer Andrea Tommasoli on February 27, 2026, effective with a six-month notice period under his French law-governed employment agreement with subsidiary InspireMD Ltd., dated November 2, 2020. Mr. Tommasoli is released from duties as of April 1, 2026, but will receive base salary through September 1, 2026, severance of approximately €61,000 gross, health benefits for up to 12 months, and accrued leave pay. The filing was signed by CEO Marvin Slosman.

• ·Employment Agreement dated November 2, 2020
• ·Common Stock, $0.0001 par value per share, trading as NSPR on Nasdaq Capital Market

04-03-2026

SES AI Corp reported revenue of $21M for 2025, surging 929% YoY from $2M in 2024, with gross profit rising 778% to $11.3M. Operating expenses declined 15% to $93.9M, narrowing the operating loss to $82.6M from $109M. However, cash used in operations was $58M (improved from $66M), investing activities showed a $39M outflow versus $108M inflow prior year, resulting in a net cash decrease of $99M compared to a $42M increase in 2024.

• ·Cost of revenue increased 1,189% YoY to $9.7M from $0.8M.
• ·R&D expenses decreased 7.1% YoY to $67M.
• ·G&A expenses decreased 30% YoY to $26.9M.
• ·Financing activities used $2M cash in 2025 vs provided $1M in 2024.
• ·No goodwill impairment as of Dec 31, 2025 following quantitative assessment.

04-03-2026

Seaport Entertainment Group Inc. (SEG) highlights strong performance at The Rooftop at Pier 17 venue, hosting 62 concerts in 2025 (up from 60 in 2024) and selling 190,000 tickets representing 89% of available inventory, with plans to expand meeting space to 41,000 sq ft for up to 1,500 guests. However, the company warns of ongoing significant negative operating cash flow and net losses expected to continue, potential adverse impacts from regulatory changes, Spin-Off tax risks, MLB PDL control over revenues, and constraints from debt service on cash flow.

• ·Rooftop at Pier 17 voted #1 outdoor music venue in NYC in 2022 by Red Bull, ranked 7th top club worldwide by Pollstar in 2025, and awarded Best Outdoor Music Venue by 2026 Rolling Stone Audio Awards.
• ·MLB PDL may control ticket tax, advertising inventory, and merchandise licensing/royalties for Aviators.

04-03-2026

On February 26, 2026, Brown & Brown, Inc.'s Compensation Committee adopted the 2026 annual cash incentive plan for named executive officers with target amounts totaling $9.4M (J. Powell Brown $5.5M, R. Andrew Watts $1.4M, J. Scott Penny $1.1M, Chris L. Walker $1.4M), weighted 40% on organic revenue growth, 40% on adjusted EBITDAC margin, and 20% on personal objectives, with payouts ranging from 0-200%. On March 3, 2026, performance stock awards (PSA Shares) valued at $17.5M were granted to three executives under the 2019 Stock Incentive Plan (0-805% payout potential over five years from January 1, 2026), tied to share price CAGR, EPS growth (adjusted), and TSR vs. S&P 500 median; additionally, $1.5M in PSUs were granted to Chris L. Walker (0-299% payout). No historical performance data or changes were reported.

• ·Cash incentive payouts adjustable by Committee to exclude unusual items.
• ·PSA Shares vest in equal increments on March 3, 2032, 2033, 2034; PSUs on March 3, 2031-2033.
• ·Measurement period for PSA/PSUs: five years from January 1, 2026.
• ·Acceleration of vesting on death, disability, or CIC-related termination.
• ·Exhibits 10.1 (PSA Agreement) and 10.2 (PSU Agreement) filed.

04-03-2026

Victory Capital's Chairman and CEO David C. Brown promoted a superior unsolicited proposal to acquire Janus Henderson Group plc at $54.15 per share ($30 cash + stock), offering JH shareholders 38% ownership in the combined company, a 37% premium over unaffected price and superior to Trian's $49 cash per share offer. Brown highlighted confidence in $500M synergies (23% of JH's cost base) based on VCTR's track record of 8 acquisitions exceeding targets, and a path to 2/3 shareholder approval despite Trian's >20% stake. However, the JH special committee has not engaged, voting math is challenging, and JH's CEO criticized VCTR's direct letter to employees.

• ·VCTR has clients in 60 countries.
• ·JH proxy statement for 2025 annual meeting filed March 28, 2025.

04-03-2026

Caesarstone Ltd. (CSTE) filed its annual 20-F report on March 04, 2026, providing comprehensive disclosures on business overview, operating and financial review, directors, major shareholders, and financial statements. The report highlights ongoing risks including economic downturns impacting home renovation demand, heavy reliance on a few large North American retailers, geographic sales concentration, challenges in US market expansion, seasonal revenue fluctuations, privacy compliance issues, and potential CFC tax consequences for US shareholders, with no specific financial metrics or performance changes detailed in the provided sections.

• ·Report covers fiscal year ending December 31, 2025 (inferred from 20-F timing)
• ·Key sections include ITEM 5: Operating and Financial Review and Prospects, ITEM 8: Financial Information

04-03-2026

Vermilion Energy Inc. filed its Form 40-F annual report for the fiscal year ended December 31, 2025, including the Annual Information Form, Management’s Discussion and Analysis, and audited annual financial statements. The company had 152,949,630 outstanding common shares as of year-end. Acquisitions included Westbrick Energy Ltd. (February 26, 2025) and Coelacanth Energy Inc., with assets in United States (July 31, 2025) and Saskatchewan/Manitoba (July 10, 2025); no specific financial performance metrics or period-over-period changes were detailed in the filing excerpt.

• ·Filing date: March 04, 2026
• ·Common shares traded on NYSE under symbol VET
• ·Operations in segments including Canada, Netherlands, Ireland, France, Germany, Australia, Central and Eastern Europe, and United States
• ·Documents filed: Exhibit 99.1 (Annual Information Form), 99.2 (MD&A), 99.3 (Audited Financial Statements)

04-03-2026

BioLargo, Inc. reported a consolidated net loss of $15.2M for the year ended December 31, 2025, more than tripling from $4.3M in 2024, driven by Clyra Medical's loss widening to $6.6M from $3.5M and ONM Environmental swinging to a $2.2M loss from a $6.0M profit; however, losses narrowed at BLEST (24% less loss), BETI, BEST, BioLargo Canada, and corporate. Selling, general, and administrative expenses increased 26% YoY to $11.8M, reflecting higher salaries (+44%), consulting (+27%), and office expenses. Total assets fell 21% to $8.3M from $10.5M, with stockholders' equity plunging 75% to $1.5M amid $11.8M added to accumulated deficit and common shares diluting to 317M from 301M.

• ·No dividends paid historically or anticipated in the future.
• ·Equity compensation: 58.8M securities under approved plans ($0.20 weighted avg exercise price), 13.8M under non-approved ($0.39), 31.2M warrants ($0.29); 25.2M shares available for future issuance under approved plans.
• ·Accounts receivable declined sharply to $0.6M from $3.2M.
• ·Clyra Medical debt obligations totaled $1.9M (net of discount), up significantly from prior year.

04-03-2026

Pasqal Holding SAS announced its business combination with Bleichroeder Acquisition Corp. II via a LinkedIn post and video on March 4, 2026, emphasizing the funding's role in accelerating commercialization, scaling neutral atom quantum processors deployed across 3 continents, and expanding globally in Europe, Asia Pacific, North America, and the Middle East. Leaders Wasiq Bokhari and Loïc Henriet highlighted increased system performance, industrial production, customer base growth, and plans for an initial NASDAQ listing in 2026 alongside a dual listing on Euronext. The communication includes forward-looking statements tempered by extensive risks, such as regulatory approvals, redemptions, and execution challenges.

• ·Final Prospectus filed by Bleichroeder on January 8, 2026
• ·Current Report on Form 8-K filed on January 9, 2026
• ·Upcoming Registration Statement on Form F-4 to include proxy statement/prospectus

04-03-2026

A Paradise Acquisition Corp., a SPAC, is pursuing a business combination with Enhanced Ltd, an unproven company with limited operating history and minimal revenue to date, planning to file a Form S-4 registration statement with the SEC. The presentation introduces Enhanced's executive team with pedigrees from organizations like the United States Olympic Committee and Barstool Sports, while highlighting initiatives like the inaugural 2026 Enhanced Games. However, it emphasizes substantial risks including regulatory scrutiny, failure to secure approvals, ethical concerns over performance-enhancement, and dependence on key personnel and financing.

• ·A Paradise IPO prospectus dated July 29, 2025.
• ·Form S-4 registration statement to be filed with SEC, including proxy statement/prospectus.
• ·Contact: The Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong; +852 9583 3199.

04-03-2026

Latham Group, Inc. reported net sales of $545.9M for the year ended December 31, 2025, up 7.4% YoY from $508.5M in 2024, though still 3.6% below $566.5M in 2023. The company swung to net income of $11.1M (2.0% margin) from a $17.9M loss in 2024, driven by gross margin expansion to 33.4% (+3.2 pp YoY) and Adjusted EBITDA growth to $99.8M (18.3% margin, +2.5 pp), while operating income rose to $30.6M (+67.3% YoY). However, SG&A expenses increased to 22.5% of sales (+1.2 pp YoY), amortization was flat at 5.3%, and 2024 sales had declined 10.2% from 2023.

• ·Basic EPS $0.10 for 2025 vs $(0.15) for 2024.
• ·Net cash from operating activities $63.4M in 2025, up slightly from $61.3M in 2024 but down from $116.4M in 2023.
• ·Cash balance $71.0M as of Dec 31, 2025, up from $56.4M as of Dec 31, 2024.
• ·Total stockholders’ equity $405.9M as of Dec 31, 2025, up from $387.2M as of Dec 31, 2024.
• ·Weighted-average basic shares 116.4M in 2025 vs 115.4M in 2024.

04-03-2026

Roman DBDR Acquisition Corp. II, a SPAC, reported net income of $7.7M for the year ended December 31, 2025, up significantly from $0.2M in the 2024 inception period, driven by $9.7M in interest income as the Trust Account grew 19.8% to $241.2M with 23M Class A shares redeemed at $10.49 per share. However, operating expenses surged nearly 11x to $2.3M, cash declined 85.6% to $0.18M, accounts payable rose to $0.9M, and shareholders' equity flipped to a $0.8M deficit from a $1.2M surplus. The company may receive up to $1.5M in Working Capital Loans convertible to warrants and has a $0.2M promissory note from a related party.

• ·Shareholders’ equity shifted to ($778,093) deficit as of Dec 31, 2025 from $1,195,391 surplus in 2024.
• ·Promissory note - related party of $200,000 outstanding as of Dec 31, 2025.
• ·Audited by firms with PCAOB ID 688 and 199.
• ·Company inception date: July 25, 2024.
• ·Filing date: March 04, 2026.

04-03-2026

Goldenstone Acquisition Limited, a SPAC, is holding a Special Meeting on March 17, 2026, to vote on proposals including extending the business combination deadline from March 21, 2026, to December 21, 2026 (via monthly one-month extensions requiring $1,500 monthly deposits into the Trust Account), removing the restriction on targets headquartered in China (including Hong Kong and Macau), and changing the company name to 'Chi Special Acquisition Company'. The Trust Account holds $5,770,865 as of December 31, 2025, with redemption price ~$13.03 per share (vs. $11.51 closing price on Record Date), but failure to approve risks liquidation and redemption of all Public Shares. Sponsor holds 1,788,750 shares with voting rights in favor.

• ·Redemption deadline: two business days prior to Special Meeting (March 13, 2026)
• ·Special Meeting dial-in: US/Canada 1-800-450-7155 or +1-857-999-9155, Meeting ID 8376052#
• ·Prior Charter amendments: September 21, 2023; June 18, 2024; June 18, 2025
• ·Fiscal year end: March 31

04-03-2026

MicroVision, Inc. reported a net loss of $95.0 million for the year ended December 31, 2025, increasing its accumulated deficit to $957.3 million. Revenue declined sharply 74.3% YoY to $1.2 million from $4.7 million in 2024, while cost of revenue surged 146.3% to $18.5 million; however, sales, marketing, general, and administrative expenses decreased 30.7% to $20.3 million. Impairment losses on intangible assets rose 140.5% to $10.1 million, and interest expense increased 315.8% to $18.5 million.

04-03-2026

Safeguard Acquisition Corp. (SAC-UN), a blank check company with no operating history or revenues since inception on June 27, 2025, reported total assets of $232.3M as of December 31, 2025, driven by $230.5M in cash and investments held in its Trust Account from 23,000,000 Class A Ordinary Shares at $10.02 per share redemption value. However, the company recorded an accumulated deficit of $7.5M and total shareholders’ deficit of $7.5M due to formation and operating costs, with total liabilities of $9.3M including a $9.2M deferred underwriting fee. It continues seeking a business combination target with significant revenue growth potential and long-term contract visibility.

• ·Balance sheet as of December 31, 2025, covering period from inception June 27, 2025.
• ·Prepaid insurance short-term: $67,508; long-term: $62,426.
• ·Audited by Independent Registered Public Accounting Firm (PCAOB ID 206).

04-03-2026

NRG Energy announced the launch of a secondary public offering of 12.3 million shares of its common stock by affiliates of LS Power, with a 30-day underwriter option for an additional 1.845 million shares; NRG will not receive proceeds. Concurrently, NRG entered a stock purchase agreement to repurchase $300 million of its common stock from the selling stockholders at the offering price, pursuant to its existing repurchase program, with closing expected alongside the offering. This follows the January 30, 2026, closing of NRG's acquisition of LS Power portfolio entities.

• ·Underwriters: Barclays and Citigroup as joint book-running managers
• ·Selling Stockholders granted 30-day option to underwriters
• ·Share Repurchase conditioned on Secondary Offering completion, but not vice versa

04-03-2026

Everspin Technologies Inc. reported FY 2025 total revenue of $55.2M, up 9.5% YoY from $50.4M, driven by product sales growth of 14.4% to $48.3M, while licensing, royalty, and other revenue declined 15.7% to $6.9M. Gross profit rose to $28.2M (51.2% margin, down slightly from 51.8%), and operating loss narrowed to $6.5M from $7.1M, but the company reported a net loss of $0.6M versus a $0.8M profit in 2024. Regionally, APAC revenue surged to $34.5M (up 20.4% YoY), North America was flat at $10.9M, and EMEA fell to $9.8M (down 11.0% YoY).

• ·Total operating expenses increased to $34.8M (63% of revenue) from $33.2M (66% of revenue).
• ·R&D expenses rose 2.9% to $14.1M (26% of revenue, down from 27%).
• ·G&A expenses up 2.9% to $14.6M (26% of revenue, down from 28%).
• ·Sales and marketing up 13.4% to $6.1M (11% of revenue, flat).

04-03-2026

Totaligent, Inc. entered into an Extension Amendment on March 4, 2026, to its Binding Letter of Intent dated February 11, 2026, with Aetherium Medical, extending the target date for negotiating definitive agreements and closing the proposed acqui-hire transaction from March 5, 2026, to March 20, 2026. The binding exclusivity period remains unchanged through April 5, 2026. This amendment allows additional time for due diligence and negotiations without altering other LOI terms.

• ·Previous disclosure in Form 8-K filed February 12, 2026
• ·Company address: 3651 FAU Boulevard, Suite 400, Boca Raton, Florida 33431
• ·Telephone: (561) 360-3565

04-03-2026

MAIA Biotechnology, Inc. (NYSE American: MAIA) announced the commencement of an underwritten public offering of common stock and pre-funded warrants, with the underwriters granted a 30-day option to purchase additional shares; the offering is subject to market conditions with no assurance of completion or terms. Konik Capital Partners, LLC (a division of T.R. Winston & Company) serves as the sole book-running manager, and net proceeds will fund clinical trials, working capital, and general corporate purposes. The offering utilizes a shelf registration on Form S-3 effective August 23, 2023.

• ·Shelf registration statement on Form S-3 (File No. 333-273984) filed August 15, 2023, and declared effective August 23, 2023.
• ·Press release dated March 02, 2026; SEC 8-K filing dated March 04, 2026.